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ABSTRACT 
 
 
 Bioelectrodynamics is the study of how electromagnetism affects the biophysical 
functions of living organisms by examining the effects on biochemical processing at the 
cellular level. The Cellular Energy Transfer Science (CETS) system modulates the 
magnetic behavior of aqueous metal ions by applying direct current (DC) with a Lorenz 
force to a hypotonic saline solution. This treated solution was then used to make growth 
media for cancerous and noncancerous cell lines in vitro. Exposure of cancerous and 
noncancerous cells to this media showed significant growth inhibition, cell cycle arrest, 
hyperpolarization of transmembrane potential and apoptosis of cancerous cells while not 
causing a growth inhibition, cell cycle arrest or apoptosis of the noncancerous cell lines. 
Microarray and RT-qPCR show the cancerous cells headed to apoptosis by the unfolded 
protein response (UPR), TNF/TRAIL, and p53 oncogene activation. Alternatively, the 
noncancerous cells show a significant increase in cell migration/wound healing after 
exposure to the treated media with no activation of apoptosis pathways. 
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CHAPTER 1.    INTRODUCTION 
 
 
BACKGROUND 
 
Eight years ago I visited a day spa where I had my first experience with a 
footbath. This footbath was recommended to me by another colleague due to the effects 
she had experienced from this experience. The footbath lasted 30 minutes and when I left 
that day, I experienced decreased joint pain, increased stamina and many other noticeable 
health improvements. This one experience catapulted me into a journey I could have 
never expected. I began to research this device and found many remarkable anecdotal 
reports across the globe ranging from increased stamina, decreased joint pain, enhanced 
wound healing, cancer treatment symptom relief, improvement in insomnia, improvement 
in renal and liver disease, enhanced plant growth and many more. Due to the alternative 
nature of this device and the footbaths, I decided it would be best to initially quantify the 
effects at the cellular/molecular level. I then approached Dr. Michael A. Whitt, Professor 
and Chair of the Department of Microbiology, Immunology and Biochemistry at the 
University of Tennessee Health Science Center and began to pursue my Ph.D. which 
began this experimental testing of this footbath device we named the Cellular Energy 
Transfer Science (CETS) system. 
 
Initially, my goal was to establish that this device/footbaths would not cause harm 
to cells or organisms. Due to the anecdotal reports of enhanced plant growth when plants 
were watered with water that had been treated by the CETS system, we decided to 
conduct an initial pilot experiment with plants to see if we would notice any difference in 
plants watered with the CETS treated water versus plants watered with the control 
(untreated) water. This initial plant experiment showed significant health differences 
between the control and treated groups so we decided to move on to and design in vitro 
experiments. Dr. Whitt suggested we begin testing with cancer cells and he provided a 
mice melanoma cell line (B16 cells) to begin our controlled in vitro experiments. We 
initially had no idea if there would be any measurable effects on the growth of these 
cancer cells and we were surprised when a significant growth inhibition was noted with 
the B16 cells that were grown in the media that was reconstituted with the CETS system 
treated water. These experiments were repeated several times and then it was decided we 
should test a noncancerous cell line to see if there was a growth inhibition of these cells. 
The CETS treated water did not cause a significant growth inhibition in the noncancerous 
cells (L929 cells-mouse fibroblasts). These unexpected findings peaked our interests and 
we decided to further pursue this body of work in order to hopefully establish the 
mechanisms behind these results. 
 
The objectives/aims that we began to pursue with regards to cancerous and 
noncancerous cells were as follows: 
 
1. To examine whether the electromagnetic field generated by the CETS system 
differentially affects the growth of cancerous and noncancerous cell lines in vitro. 
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2. To determine if cancerous cells showing a significant growth inhibition following 
treatment with CETS were displaying an arrest in a specific phase of the cell cycle. 
3. To determine differential effects of treated media and treated water at different time 
intervals on the cell growth of cancerous and noncancerous cell lines. 
4. To quantify and visualize how quickly the cancerous cells ceased to undergo mitosis 
following treatment with CETS with tubulin staining. 
5. To determine if an increase in mRNA following treatment with CETS in human 
cancerous cell line corresponds to an increase in protein production in the treated 
cells. 
6. To determine if any real time genomic changes could be measured following 
treatment with CETS in the human cancerous and noncancerous cell lines. 
7. To determine if a form of cell death is occurring after treatment with the CETS in the 
cancerous cell lines. 
 
 Due to the anecdotal reports of enhanced wound healing across the globe with the 
CETS system, the objective/aim we pursued with regards to cell migration in fibroblasts 
was: 
 
8. To determine if cell migration is affected after treatment with the CETS in a 
noncancerous/fibroblast cell line. 
 
Since the CETS system treated water was showing significant experimental 
effects, the objectives/aims we pursued with analyses of the water were: 
 
9. To determine the mechanisms that may be occurring in the water that could explain 
significant effects noted. 
10. To conduct pre-treatment and post-treatment aqueous metal ion analyses with water 
treated by the CETS. 
 
 
BIOELECTRODYNAMICS 
 
In order to understand how we might begin to study and explain these observed 
experimental effects, we began to look at the concepts of bioelectrodynamics. The subject 
of bioelectrodynamics is an interdisciplinary subject that has exhibited a rebirth in 
medical science and seeks to understand and identify the important roles that 
electromagnetism plays in biology and the biophysical function of all living organisms.1 
The existence of electrical signals in plants, animals and humans was discovered 
centuries ago.2 These electrical signals play important roles in the development, 
physiology, regeneration and pathology of cells.3 In recent decades, scientists have come 
to view these phenomena to be the result of some action rather than the mediator of cell 
physiology and have begun to see the comprehensive link between cell biology and 
bioelectricity.4 Currently in Western medicine we utilize electromagnetic signals in 
diagnostics and in the treatment for chronic disease in limited applications. The 
electrocardiogram and the electroencephalogram are used to record dynamic extracellular 
electrical signals of the heart and brain. Electrical stimulation devices such as cardiac 
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pacemakers, defibrillators, bone growth stimulators and TENS units are currently used 
for treatments of health issues. Science appears to accept these dynamic electrical signals 
but reject the little known and understood coexisting steady electrical signals of most 
other non-excitable cells. Many electrical-based therapies in the past were considered 
fraudulent and viewed with much skepticism. Western medicine currently uses the 
investigation and alteration of the biochemical signaling side of the cell through research 
on and use of pharmaceuticals, but in the last decade the scientific literature has begun to 
address the role that electromagnetism could play in treating health issues.4 
 
 
Newtonian versus Quantum Physics 
 
Prior to the beginning of the 20th century, science embraced Newtonian physics as 
the basis for life processes.6 Concepts based in Newtonian physics refer to the 
organizational structure of matter in which the smallest known particle, the atom, consists 
of protons, neutrons and electrons. Western practitioners believed that all things could be 
divided into parts of the whole. This emphasis on particle theory led to the belief that if 
you could affect one particle or pathway of the cell/atom that has gone awry, health could 
be restored. This became the basis for the pharmaceutical industry explosion and 
development of small molecules (medications) that affected specific cell signaling 
pathways normally controlled by the binding of hormones, cytokines, growth factors, 
ions, messengers etc., to their cognate receptors. 
 
Alternative views of how energy and health are related with regards to quantum 
physics was first recognized by Chinese practitioners thousands of years ago.7 They 
realized that when the measurable energy fields of an organism are strong, the organism 
remains healthy; when it is weak the organism becomes vulnerable to sickness and 
ultimately death. Quantum physicists suggested that “atoms” or matter are actually 
energy fields that are constantly spinning, moving or vibrating.6,8,9 The concept that 
energy and matter are one in the same was recognized and described by Max Planck who 
is considered the father of quantum theory.10 He stated that energy € is equal to a constant 
(h) multiplied by its frequency (v) or € = hv. Therefore, it is impossible to separate living 
organisms into energy and matter since they are coexistent and it stands to reason that we 
should consider and not ignore the role that energy and its associated energy fields can 
play in affecting living matter (organisms). 
 
Bioelectrodynamics recognizes that living organisms are energetic beings and 
each have individuality that is based in the make-up of its subatomic particles but there is 
a commonality which resides on the energy frequency side of their physical composition. 
In bioelectrodynamics an organism can be viewed as vibrating fields of energy. An 
organism’s DNA sequence defines its constituent physical properties but there is also a 
unique frequency or pattern of energy that makes it unique.11 
 
The environment, organism and individual cells are an integration of 
interdependent energy fields. Organisms are affected by the energy field of other 
organisms around them.12 Flow of energy is information in the quantum world and is 
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holistic meaning the whole being and not one specific chemical pathway is involved in 
the energy ebb and flow. Since Newtonian physics divides living organisms into 
individual parts and targets their cell signaling pathways through the use of biochemical 
means, this creates a series of interconnected events that can lead to unwanted upstream 
and downstream effects. As one delves into the metabolic processes of the cell, it does 
not take long to realize the complicated and multidimensional nature of the cell and how 
quickly changes are occurring in multiple pathways simultaneously.13 Energy medicine 
has the ability to simultaneously enhance many biological processes that are necessary 
for and are the basis of life. Electromagnetic energy fields are absorbed by all excitable 
and non-excitable cells in the organism and affect and enhance multiple pathways at the 
same.14 
 
Bioelectrodynamics can utilize an electrical energy source that affects not only 
the organism but the field immediately surrounding the organism. The tertiary interaction 
of these three components: 1) energy source, 2) environment, and the 3) organism are all 
involved in the process of bioelectrodynamics. The energy source can consist of 
regulated electrical current (alternating current/AC or direct current/DC) delivered 
through a specifically designed power pack, natural sources that emit electrical fields 
such as lightning, sunlight, cosmic radiation, or other man-made devices such as cellular 
phones, microwaves, electrical power lines, televisions, other living organisms and 
surrounding objects. The environment is the immediate area surrounding the organism 
(cell or individual) such as the extracellular matrix of the cell as well as the energy field 
surrounding the organism (person). If electromagnetic fields generated by the energy 
source, the organism/cell and the environmental field interact either positively or 
negatively, physiologic processes of the living organism can be affected in a quantum or 
tertiary fashion.14,15 When an energy emanates from an appropriate source that is 
beneficial to the living organism this energy becomes bioenergy and will be utilized and 
absorbed by the whole organism to be used for cell physiological processing. Multiple 
cell signaling pathways of the whole organism will be affected by an external 
electromagnetic energy source in a harmonic vibration with the environment. 
 
 
Veritable versus Putative Energy Fields 
 
The National Center for Complementary and Integrative Health has divided 
energy medicine into veritable applications or those that can be measured for diagnosis 
and treatment, and putative applications (biofields), those that have defied measurement 
by lack of reproducibility.16 Eastern medicine applications have historically been 
considered putative by involving a health practitioner and a client with the practitioner 
addressing the electromagnetic fields of the whole living organism through such methods 
as acupuncture, reflexology, massage, healing touch, Reiki etc. Putative energy fields 
have been the most controversial of the alternative energy medicine practices but they are 
gaining popularity in the American marketplace as well as academic medical centers 
where 85% of medical schools offer elective courses in these alternative health 
practices.16 
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Recent veritable research has demonstrated that remarkable effects on the health 
of a living organism can be acquired by addressing its electromagnetic field.17 Moreover, 
it is known that organisms must process environmental electromagnetic signaling to 
survive and these signals are indeed now measurable with recent advances in medical 
science.12 The speed of an electromagnetic energy signal is 186,000 miles per second and 
the speed of a chemical reaction is less than 1 cm per second.6 This indicates how much 
more efficient a holistic electromagnetic signal operates that is based in quantum theory 
compared to a chemical signal which is based in Newtonian theory. These new 
measurement tools in the field of nanotechnology and the development of veritable 
energy medicine applications have the potential to produce significant and reproducible 
research findings and clinical results that will offer credible and valid applications in 
Western medicine. 
 
 
LITERATURE REVIEW 
 
We can measure transmembrane potential (Vmem) of cells, a phenomena 
resulting from differential ion concentrations across the cell membrane.18,19 We know that 
cell behavior is regulated by not only chemical gradients but also by bioelectric cues.12 
Vmem differences have been found in cancerous, injured and proliferating cells.19,20 
Cancerous, injured and proliferating cells have a more depolarized membrane potential of 
approximately < -30mV, while noncancerous cells have a resting potential of > -70mV.19 
Cells have been found to respond to different electromagnetic signals when undergoing 
division, migration and differentiation.2 Furthermore, scientists have found that 
bioelectricity or electromagnetic fields involve the changing gradients of transmembrane 
potential, ion channel activity and electromagnetic fields that are produced and sensed by 
non-excitable cells in living organisms.1,20,21 Therefore, bioelectricity shows an effect 
well beyond excitable cells and has been shown to affect wound healing, cell migration, 
nerve growth, limb regeneration and cancer.3,22 Changes in transcription, after 
depolarization of the cell membrane, occurs across multiple genes and it appears that 
bioelectric cues or signals override chemical signals since human mesenchymal stem 
cells will not differentiate without hyperpolarization in spite of potent chemical 
inducers.23 
 
Bioelectric gradients have also been found to mediate signaling beyond cell to cell 
communication and actually appear to communicate throughout the whole organism and 
beyond.12 This suggests that bioelectric cues are a very efficient medium for carrying 
information. For example, planarian flatworms can remarkably regenerate themselves 
from partial body fragments.24The partial body fragments require communication to 
control whether the regrowth occurs symmetrically or asymmetrically where one edge 
becomes a head or becomes a tail in order to grow the entire whole organism. The cells 
must be able to conduct long-range communication since gap junction (cell-cell) 
communication would not suffice for this high level differentiation from the remaining 
partial body fragments.25 
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It has also been shown that electrical events tell the cells what to do; voltage 
changes have been found to be a sign of cancer as well as determine whether or not 
cancer may develop.20 In addition, a research group at Tuft’s University has found that in 
addition to cells being regulated by their own internal voltage potential they are also 
regulated by surrounding organisms, as well as the environment.12 This finding opens the 
door for potential research in the areas of cancer, wound care and any other disease 
process that can be attributed to a depolarized Vmem that leads to cell damage, 
inflammation, and death.19 The four cardinal signs of inflammation are: redness, 
swelling, heat and pain; the fifth cardinal sign of inflammation is loss of function.26 Since 
loss of function is thought to originate with inflammation of the cell, Vmem augmentation 
with bioelectromagnetic energy could offer a new treatment options for chronic disease. 
To test this hypothesis, a single-group open label phase I/II trial was performed to assess 
the safety and efficacy of intrabuccal administration of low levels of electromagnetic 
fields in patients with advanced hepatocellular carcinoma. The results of this study 
indicated that treatment with low levels of 27.12 MHz radiofrequency electromagnetic 
fields was associated with a decrease in tumor size that is mediated by genetic expression 
as well as increased progression-free survival for > 6 months in the participants.17 
 
 
DISCUSSION 
 
These in vitro experiments and in vivo human trials demonstrate the potential of 
electromagnetic fields as diagnostic tools and as treatments for disease. Now that tools 
have been developed that can quantify processes on the cellular level, including the 
effects of electromagnetic fields and bioelectricity on living organisms; research on 
examining the mechanisms by which cells interact with bioelectrical signals, chemical 
gradients and physical forces has begun to emerge.32,33 Subsequently, molecular analysis 
of the effects of bioelectricity may point us to a way we can understand the mechanisms 
that occurs at the cellular level and lead us to biomedical transformations. The concepts 
of bioelectrodynamics gave us a basis for pursuing these in vitro effects from the 
application of electromagnetic fields by the CETS system. The methods we adopted were 
based on the applications to people, plants and animals that have been used across the 
globe for 20 years. In Chapters 2, 3 and 4, we will begin to pursue our aims in order to 
quantify in vitro effects that the CETS system treated water has on cancerous and 
noncancerous cells. These in vitro experiments may open the door for future applications 
of veritable quantum physics in Western medicine. 
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CHAPTER 2.    HYPERPOLARIZATION OF PLASMA MEMBRANES 
THROUGH MAGNETIC MODULATION OF AQUEOUS METAL IONS 
 
 
INTRODUCTION 
 
Water is the most abundant chemical in all living things and makes up 80% of all 
living organisms. Almost two decades ago, a device was invented in Australia that 
utilizes 2.5 amperes of direct current (DC) that is applied perpendicularly to a 
module/array of copper and stainless steel plates. This device, the Cellular Energy 
Transfer Science system (CETS) creates a bio-charge, which can be defined as a form of 
organic or bio-electricity, from an artificial energy source that can be applied to living 
organisms through a medium of water. The CETS has been widely sold across the globe 
in holistic markets and administered in the form of footbaths and baths with reports of 
pain relief, increased stamina, improvements in renal and hepatic function, support in 
cancer treatment recovery, decreased recovery time from illness and injury and many 
other health applications.15 Users of this device immerse part or all of their body in the 
water for 20–35 minutes every other day. The device has been approved by the 
Therapeutic Goods Administration to be marketed as a therapeutic device in Australia. 
The current manufacturer in the United States reports that approximately 15,000 units are 
sold yearly with over two million footbaths/baths given worldwide to date since the 
invention was marketed (S. Walker, personal communication). 
 
It has been shown that cell behavior is regulated by chemical gradients as well as 
bioelectric cues.12 Plasma membrane potential (Vmem) differences which represent these 
cues have been found to differ for cancerous, injured and proliferating cells.20,21 
Cancerous, injured and proliferating cells have a measurable depolarized membrane 
potential of approximately < -30mV, while noncancerous cells have a resting potential of  
> -70mV.19 Cells have also been shown to respond to different electromagnetic signals 
when undergoing division, migration and differentiation.2 In addition, electromagnetic 
fields have been found to induce gradient changes of Vmem that are produced and sensed 
by non-excitable cells and in living organisms.20,21 Therefore, bioelectricity has been 
shown to induce effects beyond excitable cells and to affect wound healing, cell 
migration, nerve growth, limb regeneration and cancer.1,3,22 Due to the interesting 
anecdotal testimonials, the therapeutic uses of the CETS system from across the globe, 
and the scientific basis for membrane potential differences in cancerous, injured and 
proliferating cells; we undertook testing at the molecular level to quantify what, if any, 
effects were occurring to drive these widespread claims. 
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METHODS 
 
 
Cells and Cell Culture Medias 
 
Four cell lines were used for this investigation: B16 cells (murine melanoma), 
L929 cells (mouse fibroblasts), MDA-MB231 cells (human triple negative breast cancer) 
and MCF-10A cells (human breast epithelial cells). The L929, MDA-MB231 and MCF-
10A cells were obtained from ATCC and the B16 cells from the laboratory of Dr. Larry 
Pfeffer (Department of Pathology, UTHSC). The B16, L929 and MDA-MB231 cells 
were all cultured in 1X Dulbecco’s Modified Eagles Medium (#D6429) with 10% Fetal 
Bovine Serum (DMEM-10) from Atlanta Biologicals. To prepare 1X DMEM, a 10X 
DMEM (#D2429) solution was diluted 9:1 with a hypotonic (3mM) saline solution that 
had been treated for 30 minutes with the CETS system and filtered through Corning 
bottle top cellulose acetate membrane vacuum 0.22 micron filter (CLS430521, Sigma). 
The hypotonic saline solution was made using deionized water from the laboratory and a 
5M sodium chloride (Molecular Biology grade- #V4221, Lot # 18693201 
DNase/RNase/Protease free) solution from Promega Corporation. The medium was 
supplemented with the appropriate concentrations of folic acid, 0.004gm/L (Sigma-
Aldrich-F8758-5G, Lot # SLBF 16021), glucose 4000mg/L (Sigma-Aldrich G7021-
100G, Lot # 071N01455), glutamine 0.584gm/L (Sigma-Aldrich-G7513, Lot # 
RNBC5892) and sodium bicarbonate 3.7gm/L (Biowittaker # 15-6131) in order to obtain 
the exact concentrations of standard DMEM.  Fetal bovine serum was added to the 
diluted DMEM to achieve a 10% concentration. 
 
The MCF-10A cells were cultured in DMEM/F12 (Invitrogen #11330-032) with 
5% Horse Serum (Invitrogen # 11330-032) that was made by adding EGF, 
Hydrocortisone, cholera toxin and insulin.  In order to make the treated and control 
media, we used DMEM 10X (Sigma-# D2429 diluted 9:1 and F-12 Nutrient Mix powder 
(Life technologies # 21700-026) mixed to manufacturer protocol specifications using 
either treated or control saline. The diluted DMEM and F-12 media was then mixed 1:1 
was filtered through a 0.22 micron filter and then combined with appropriate 
concentrations of EGF 20ng/ml (PeproTech 100-47), hydrocortisone 0.5mg/ml (Sigma-
Aldrich #H-0888), cholera toxin 100ng/ml (Sigma-Aldrich #C-8052) and insulin 10 
mcg/ml (Sigma-Aldrich #I-1882).  Horse serum was then added to obtain a 5% 
concentration in the cell culture media. 
 
 
Cell Growth Studies 
 
We cultured the treated groups of B16, L929 and MDA-MB231 cells in the 
DMEM-10 with media that was reconstituted with a hypotonic saline solution that had 
been treated with the CETS system for 30 minutes and the control groups of each of the 
three cell lines were cultured in media that was reconstituted with the same hypotonic 
saline solution prior to treatment with the CETS system. The treated group of MCF-10A 
cells was cultured in the DMEM/F12-5 media that had been reconstituted with a 
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hypotonic saline solution that had been treated with the CETS system for 30 minutes and 
the control group was cultured in media that was reconstituted with a hypotonic saline 
solution that had not been treated with the CETS system. On day one, aliquots of 10,000 
cells were plated in three 6-well plates for each of the two groups for each of the four cell 
lines. They were plated in their standard (non-CETS treated) DMEM-10 or DMEM/F12-
5 media on day 1.  On day 2, the treated (n=18) and control (n=18) media for each of the 
four cell lines were made and the original standard media was replaced in each of the 
wells with the newly prepared treated and control media. On days 3 through 7, wells from 
the control group and treated group of each cell lines were trypsinized, removed from 3 
wells of each group and counted using a Scepter cell counter (EMD Millipore). 
Remaining wells had the control and treated media replaced daily with freshly prepared 
treated or control media unless otherwise specified in the figure legends. 
 
 
Cell Cycle Analyses 
 
Cell cycle analyses were performed with each cell line that were grown in treated 
versus control media for three days with the media replaced daily with freshly made 
treated or control media. The cells were trypsinized and washed twice with phosphate 
buffered saline (PBS) containing 0.1% FBS and subsequently fixed with -20o C ethanol 
by adding drop wise to the pellet while vortexing to minimize clumping. After overnight 
incubation at 4o C, the cells were washed twice with ice cold PBS by centrifugation at 
850g for 5 minutes and re-suspended at a final concentration of 1,000,000/ml in a total 
volume of 300 microliters. The cell suspensions were placed in PBS after treating with 
DNase free RNase (50 mcl of a 100 mcg/ml stock RNase) to remove all remnants of 
RNA and then stained with 200 microliters of propidium iodide (50 microgram/ml stock) 
prior to cell cycle flow cytometry. The data were analyzed using ModFit LT software. 
 
 
Cell Death Assay 
 
Annexin V-FITC Apoptosis Detection Kit (APOAF Sigma-Aldrich) was used to 
conduct an apoptosis assay on the murine melanoma and the human breast carcinoma. 
After initiating apoptosis, cells translocate the membrane phosphatidylserine (PS) from 
the inner face (cytoplasmic side) of the plasma membrane to the cell surface. Once the PS 
is on the cell surface from the failure of flippase, it can be easily detected by staining with 
a green fluorescent protein, Annexin V that has a high affinity for PS. Propidium iodide 
(PI) was also added with this assay to detect the cells that have already undergone 
necrosis/cell death. Because PI enters the cell membrane of dead cells, it differentiates 
apoptotic from the dead cells. The MDA-MB231 and B16 cells were plated (1 x 106) and 
grown in treated and control media in 60mm plates for 3 days before performing the 
experiments. They were then typsinized and removed and washed twice in PBS. The 
pellet of treated and control cells were then resuspended in 500 mcl of 1x Binding Buffer 
at a concentration of 1 x 106   cells/ml. Then 5 mcl of annexin V-FITC and 10 mcl of 
propidum iodide were added to the cells. The cells were then analyzed with cell flow 
cytometry and microscopy. 
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Membrane Potential Analyses 
 
Membrane potential analyses were performed on all four cell lines using Five-
Photon Membrane Potential Assay (Five-Photon Biochemical). This assay utilizes a 
membrane permeant dye formulation of oxonol dyes for transmembrane potential 
measurement. Membrane potential assay dyes enter depolarized cells and bind to their 
intracellular membranes or proteins that leads to enhance fluorescence. An increase in 
depolarization leads to an elevated influx of the voltage sensitive dye and an increase 
fluorescence that can be measured by fluorescent microplate readers or flow cytometers.  
After washing twice with PBS to remove serum factors, 60,000 cells were plated in the 
wells of a 96-well plate and placed in 100 mcl of serum-free media. The wells were 
plated with both the treated and control groups of each cell line. The cells were exposed 
to the treated and control serum-free media for the time points of: 45 minutes, 12 hours, 
24 hours and 72 hours prior to the addition of 100 mcl External Assay Buffer to make a 
1X dye solution and 200 mcl was added to each well. The cells were then incubated in 
the dark at 37 degree Celsius in a CO2 incubator for 20 minutes to load the dye prior to 
placing in a fluorescent plate reader. The fluorescence was measured in the 530 excitation 
\wavelength (nm) and 565 emission wavelength (nm) with a 550 emission cut-off (nm). 
The lipophilic, anionic dye partitions across the plasma membrane of live cells and is 
dependent on the membrane potential across the membrane. When the cells are 
depolarized, more indicator dye enters the cells causing an increase in fluorescence 
signal. 
 
 
BCA Protein Analyses 
 
The MDA-MB231 cells were plated (3 x 10 6) in two 10cm plates and grown in 
treated media and control media. Media were change daily until confluence. BCA Protein 
Assay Reagent Kit (Pierce 23225 23227) is a detergent-compatible formulation based on 
bicinchoninic acid (BCA) for the colorimetric detection of quantitation of total protein 
was used for this analysis. This method utilizes a well-known reduction of copper by 
protein in an alkaline medium with sensitive and selective colorimetric detection of the 
cuprous cation.  The cells were trypsinized and pelleted using 500 rpm for 5 minutes, 
then lysed in 300 mcl of mammalian cell lysis buffer (Abcam ab179835). Total protein 
concentration was determined using the microplate procedure and the dilution parameters 
of 0, 200, 400, 600, 800 and 100 micrograms/ml were made according to the preparation 
of diluted albumin (BSA) standards with 50 parts of BCA Reagent A with 1 part BCA 
Reagent B (50:1, Reagent A:B). Once the dilutions were made, 25 mcl of each standard 
and unknown sample replicates were pipetted into the microplate wells. Prior to placing 
wells in a 37 degree Celsius incubator for 30 minutes, 200 mcl of the working reagent 
was added to each well. The plate was then cooled to room temperature and measured at 
the absorbance of 562 nm on a plate reader. 
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RT-qPCR Analyses 
 
In order to validate some of the significant genomic effects seen in the microarray 
analysis on the MDA-MB231 cells, we conducted Real-Time qPCR using LC 480 and 
UPL probes.  Ten genes were chosen: (1) CHaC glutathione-specific gamma-
glutamylcyclotransferase 1 (CHAC1), (2) Endoplasmic Reticulum to Nucleus Signaling 1 
(ERN1), (3) Homocysteine-Inducible, Endoplasmic Reticulum Stress-Inducible, 
Ubiquitin-Like Domain Member 1 (HERPUD1), (4) Tumor Necrosis Factor Receptor 
Family 9 (TNFRSF9), (5) Junction-mediating and regulatory protein of p53 (JMY), (6) 
Cyclin E2 (CCNE2), (7) Hyaluronan-mediated motility receptor (HMMR), (8) DNA-
Damage-Inducible Transcipt 3 (DDIT3), (9) Caspase 4 (CASP4), (10) Chloride 
Intracellular Channel Protein 4 (CLIC4) and RIBOPROTS19 (housekeeping).  The 
primers were designed using universal probe library. Transcriptor First Strand cDNA 
Synthesis Kit (Roche Cat. No. 04 379 012 001) was used to make cDNA with the original 
microarray samples. Then the following reagents were added to the wells in the 
appropriate measurements according to the protocol in order to make 8mcl of this master 
mix for each well used in the 5-dilution factors (in triplicate) of the cDNA: universal 
library probe (UPL probe, Roche) at 10uM, LC480 master mix (2X concentration, 
Roche), mixed left and right primers at 10uM each in DNase, RNase & Protease-free 
water (Corning cellgro, # 46-000 Cl), and nuclease free water. The five dilutions of 
cDNA were: undiluted, 1:10, 1:100, 1:1,000, 1:10,000. The 8 mcl of the master mix and 2 
mcl of the cDNA were added to wells of a 96 well plate. The plates were centrifuged and 
activated for 5 minutes at 95 degrees. Then there was an amplification of 45 thermal 
cycles using 500C for 2 minutes (separation), 950C for 10 minutes (initialization) and 
950C for 15 seconds (denaturation), and 600C for 1 minute (annealing), and 70-740C for 5 
minutes (elongation). The amplicons were then plotted for validation. 
 
 
RESULTS 
 
 
Differential Effects on Cancerous and Noncancerous Cell Growth 
 
Cell growth studies were conducted to examine whether the electromagnetic field 
generated by the CETS system differentially affected the growth of cancerous and 
noncancerous cells lines in vitro. We observed a significant growth inhibition of doubling 
times between control and treated groups of both the murine melanoma and human breast 
carcinoma cell lines when maintained in CETS-treated media while there was little to no 
growth effect on the noncancerous murine fibroblasts or human breast epithelial cells 
(Figure 1). Growth rates and doubling times (Table 1) extracted from this analysis could 
then be compared using the Mann-Whitney U-test. This nonparametric test does not 
require a normal or Gaussian distribution. The measurements of the growth rate are 
independent since each replicate represents a different culture dish. The data were also 
log-transformed to fit a linear mixed effects model. Significance between the cancerous 
cell control and treated groups was declared with both methods with an alpha of < 0.05.  
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Figure 1. Cell Growth/Time in Control and Treated Media. 
~ 10,000 cells were plated in standard media in triplicate for each cell line. Control and 
treated media were reconstituted daily with CETS control/treated water and replaced 
daily.  Wells were counted in triplicate daily with three repeats. Growth rate with Mann-
Whitney U-test (p < 0.05). (A) Murine melanoma-Z-score is 3.4486; p = 0.00056; U-
value is 52.5; CV-99. (B) Murine fibroblasts-Z-score is 0.4276; p = 0.6672; U-value is 
203; data are normal and z-value can be used. (C) Human breast carcinoma –Z-Score is 
4.3978; p = 0; U-value is 22.5; CV-99. (D) Human breast epithelial cells-Z-score is-
0.8701; p = 0.3843; U-value is 134; data are normal and z-value can be used. 
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Table 1. Doubling Times of the Four Cell Lines Using the Exponential Growth 
Equation of the Non-Linear Regression Analysis Function of Prizm GraphPad v 
5.04. 
 
Cell Line Control Treated 
Mouse melanoma (B16-F10) 30.5 hours > 7 days 
Mouse fibroblast (L929) 21.5 hours 21.5 hours 
Human breast cancer (MDA-MB-231) 23.0 hours > 7 days 
Human breast epithelium (MCF-10A) 24.6 hours 28.1 hours 
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There was no significant difference in the growth rates of the noncancerous cell control 
and treated groups with both methods. 
 
We then proceeded to determine how long the effects of the treated water that was 
used to reconstitute the growth media would retain the effects that led to the significant 
growth inhibition of cancerous cells. The first set of experiments was conducted with 
treated water that was made fresh daily to make the growth media that was changed daily 
in the wells over 7 days. To determine how long the effect lasted, we treated water with 
the CETS system and allowed the treated water to sit for set time periods of 2, 3, 7and 14 
days prior to making the treated media which was prepared and changed daily. For 
example, in the “2 day old” sample, media was prepared using treated or control dilute 
saline beginning 2 days post treatment and the media was prepared daily using the same 
solution therefore on days 2-7. We observed a significant growth inhibition of growth in 
all samples demonstrating the effect is maintained for up to two weeks after initial 
treatment with the CETS system (Figure 2). 
 
 
Differential Effects on the Cell Size of Cancerous and Noncancerous Cells 
 
Due to the observed microscopic changes in cell morphology that were noted in 
the experiments and the fact that cell size is known to decrease when cells undergo 
various changes such as cell cycle progression and apoptosis, cell size data was collected 
using the Scepter 2.0 Cell Counter (Merck Millipore) and analyzed with unpaired t-tests. 
There was a significant difference in cell size between the treated and control groups in 
the cancerous cells while no significant difference was detected in the noncancerous cells 
lines (Figure 3). The MDA-MB231 cells show the largest significance and the data 
suggest that the cell size increases initially in the treated group and begins to decrease or 
shrink on day 6 (Figure 4). 
 
 
Differential Effects on the Cell Growth of Media Made on Day 1 Only 
 
In order to determine if the effects on the growth inhibition of cancer cells 
required daily making of replacement media that was made only on day 1 and not made 
fresh daily like the original growth experiments, we conducted the experiments by 
making growth media on day 1 and used the media made on day one to replace the 
control and treated media daily with the murine melanoma and the human breast 
carcinoma. After cell counts were conducted until day 7, the effect of growth inhibition 
appeared to wear off at around day 6 but the murine melanoma and human breast 
carcinoma showed an overall growth inhibition (Figure 5). 
 
 
Differential Effects on Cell Cycle Progression of Cancerous and Noncancerous Cells 
 
In order to determine if the cancerous cells that were showing a significant growth 
inhibition were displaying an arrest in a specific phase of the cell cycle, cell cycle  
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                 C                                                               D 
 
Figure 2. Growth Rate of MDA-MB231 Cells in Media Reconstituted from 2, 3, 
7 and 14 Day Old Water. 
~10,000 MDA-MB231 cells were plated in standard media and after one day of growth 
the standard media was replaced with control or treated media daily.  Control and treated 
media were made from 2, 3, 7, or 14 day old water and replaced daily. Wells were 
counted in triplicate daily from both control and treated groups. MDA-MB231 cell 
growth rates using Mann-Whitney U tests (p < 0.05). (A) 2-7 days-Z-score is 3.1164; p = 
0.0018; U-value is 63; CV =99. (B) 3-9 days-Z-score is 3.8866; p = .0001; U-value is 
65.5; CV= 99. (C) 7-13 days-Z-score 3.3583; p = 0.0078; U value 86.5; CV = 99. (D) 14-
20 days-Z-score 3.2828; p = 0.00104; U- value is 89.5; CV = 99. 
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Figure 3. B16, L929, MDA-MB231, MCF-10A Cells Size with Sceptor 2.0 Cell 
Counter (Merck Millipore). 
Cell size was analyzed by counting/analyzing cell size daily while counted in triplicate 
for 7 days while treated and control groups of each cell lines were grown in the control 
and treated media. The results shown are the means of cell size for days 1-7. Unpaired t-
tests show a significant difference in cell size between the treated and control groups of 
the cancerous B16 and MDA-MB231 cells. There is no significant difference noted 
between the noncancerous L929 and MCF-10A cells. 
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Figure 4. MDA-MB231 versus MCF-10A Daily Cell Size Analysis. 
When analyzing the daily cell size changes, the MDA-MB231 treated cells (red) show an 
increase in cell size on days 1-5 when compared to control (blue) and then appear to have 
a drop in cell size on day 6. The MCF-10A cells appear to be larger when initially placed 
in the treated (red) and control (blue) media, but overall have uniform size between 
control and treated cells from day 1-6. 
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Figure 5. Effect of Storing Media on Cell Growth Inhibition. 
Control and treated media for (A) B16 and (B) MDA-MB231 cells were made on day 1 
and this media made on day 1 were used to replace the control and treated media daily. 
Cells were counted daily in triplicate. B16 Cells cultured in media prepared on Day 1 
(media changed daily) unpaired t-tests; mean (C) 656795; mean (T) 186,752.4; p = 
0.032002; ts = 2.222029; df = 40. MDA-MB231 cells cultured in media prepared on Day 
1 (media changed daily) unpaired t-tests; mean (C) 676232.1; mean (T) 220645.7; p = 
0.016367; ts = 2.506314; df = 40. 
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analyses were conducted on all four cell lines with cell flow cytometry utilizing ModFit. 
When compared to controls, CETS-treated murine melanoma did not enter in S phase and 
showed a two-fold increase G0/G1 phase while treated MDA-MB231 cells were halted in 
S and G2/M phases were unable to complete mitosis (Figure 6). 
 
 
Differential Effects of the Modulation of the Magnetic Behavior of Metal Aqueous 
Ions on the Mitotic Index of Cancerous Cells 
 
In order to quantify and visualize how quickly and if the cancerous cells ceased to 
undergo mitosis, human breast carcinoma cells were grown in control or treated media 
for one day. The cells were then fixed and stained with DAPI to visualize the nuclei and 
with an anti-tubulin antibody followed by a rhodamine-conjugated secondary antibody.  
The untreated control cells had ~17% of the cells undergoing active cell division, 
whereas cells grown in the treated media showed some nuclear condensation, but no 
detectable mitotic spindle formation (Figure 7). 
 
 
Effects on the Membrane Potential of Cancerous and Noncancerous Cells 
 
Due to the known Vmem differences in cancerous, injured or proliferating cells, 
we decided to conduct membrane potential assays on all four cell lines. We hypothesized 
that the treated media would have a differential effect on membrane potential of the 
treated versus control cells. Upon analysis of the data, we found that all four cell lines 
showed rapid hyperpolarization of the cells when placed in media that occurs in the first 
45 minutes. When the cells are hyperpolarized the indicator dye exits the cells, resulting 
in a decrease in fluorescence signal. All four cell lines remained hyperpolarized while 
maintained in the treated media (Figure 8). Percent differences between the treated and 
control groups show the noncancerous cells return closer to baseline at 24 hours post-
treatment, while the cancerous cells remain in a more hyperpolarized state (Table 2). 
 
The results indicate that all four cell lines undergo a rapid hyperpolarization and 
remain hyperpolarized during maintenance in the treated media. In the microarray 
analysis delineated below, gene CLIC4 was upregulated 2.75 times which is a chloride 
channel made up of a diverse group of proteins that stabilize cell membrane potential, 
trans-epithelial transport, maintenance of intracellular pH and regulation of cell volume. 
 
 
Differential Effects on Cell Death by Phase and Fluorescent Microscopy 
 
In Figure 9, we left the breast carcinoma growing in treated media for 14 days 
and the control cells grew for 5 days until confluence. The treated cells in Figure 9 
(right) show the cells rounding up off the bottom as well as cell shrinkage, nuclear 
condensation and blebbing when compared to the control cells in Figure 9 (left). Due to 
the significant cell growth inhibition, cell cycle arrest and the observed effects of cell 
shrinkage (Figure 4), nuclear fragmentation and “blebbing” (Figure 9) we proceeded to  
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Figure 6. Cell Cycle Analysis Using Propidium Iodide and Cell Flow 
Cytometry. 
A) Treated murine melanoma did not enter in S phase and showed a two-fold increase 
G0/G1 phase while treated (B) Treated L929  (C) Treated MDA-MB231 cells were 
halted in S and G2/M phases were unable to complete mitosis. (D) Treated MCF-10A 
cells had no change in the cell cycle. 
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Figure 7. Tubulin Staining of MDA-MB231 Cells after Growth in Both Control 
and Treated Media for One Day. 
Cells were fixed and stained with DAPI to visualize the nuclei and with an anti-tubulin 
antibody followed by a rhodamine-conjugated secondary antibody. A). The human breast 
carcinoma were then grown in control or treated media for one day and were fixed and 
stained DAPI to visualize the nuclei and with an anti-tubulin antibody followed by a 
rhodamine-conjugated secondary antibody. The untreated control cells (left) had ~17% of 
the cells undergoing active cell division (arrows), whereas cells grown in the treated 
media (right) showed some nuclear condensation, but no detectable mitotic spindle 
formation. B) Higher magnification of A. 
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Figure 8. Membrane Potential Assay. 
Percent increase was noted between control and treated groups of MDA-MB231, MCF-
10A, B16 and L929 cells after exposure to treated media for the time points of 45 
minutes, 8 hours and 24 hours. Cells were analyzed using Five Photon’s membrane 
potential assay. The graphs show change in fluorescence over time. When a cell is 
depolarized the fluorescence increases and when it is hyperpolarized the fluorescence 
decreases. Table 2 shows percent change between control and treated cells at the specific 
time points below. 
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Table 2. Percent Change in Membrane Potential. 
 
Cell Line 45 Minutes in 
Treated Media 
as Compared to 
Controls 
8 Hours in 
Treated Media 
as Compared to 
Controls 
24 Hours in 
Treated Media 
as Compared to 
Controls 
MDA-MB231 ↑70% ↑61% ↑32% 
MCF-10A ↑94% ↑31% ↑12% 
B16 ↑60% ↑29% ↑34% 
L929 ↑76% ↑35% ↑06% 
 
 
 
 
 
 
Figure 9. MDA-MB231 Cells Control versus Treated for 14 days. 
Control (left) Treated (right). 
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conduct an Annexin V-FITC Apoptosis Detection assay utilizing cell flow cytometry. 
Upon completion of the cell flow analysis, we were unable to differentiate treated stained 
and unstained in order to quantify the effect of interest. We then proceeded to phase and 
fluorescent microscopy of the stained treated and unstained treated cells and we found the 
treated cells displayed an auto-fluorescence in all color spectrums. Auto-fluorescence 
interferes with detection of specific signals and is a natural emission of light by biological 
structures such as mitochondria and lysosomes when they have absorbed light. The 
treatment appears to induce auto-fluorescence and therefore the cell flow cannot 
differentiate between the different groups. We did note there was a visible staining of 
areas of the membrane in the treated group of the breast carcinoma in the FITC channel 
representing annexin V staining when examined with fluorescent microscopy while there 
was none noted in the control group (Figure 10). Figure 11 shows the different 
microscopic appearance in the phase contrast pictures of the control and treated stained 
cells. 
 
Another interesting observed phenomena occurred when these cells in Figure 9 
were placed back in standard DMEM, it appears that the cells that were rounding up and 
appearing to undergo a cell death have continued to become apoptotic and form 
disorganized cell clusters while the cells that were growing have continued to grow and 
divide, albeit in with a different morphological appearance and at a slower rate since this 
cell line characteristically becomes confluent in less than 5 days (Figure 12). We also 
conducted an experiment where we grew MDA-MB231 cells in control and treated media 
for 7 days and then placed both groups back in control media. On analysis of four 
different groups: control days 1-7, control days 8-14, treated days 1-7 and treated days 8-
14, we found that there was no change in the growth of the control group but there was a 
decreased growth rate in both the treated groups when compared to control (Figure 13). 
There was also a decreased growth curve noted in the treated cells when placed back in 
the control media on day 8 when compared to the treated cells on days 1-7 and the 
control cells on days 1-7. This suggests there may be a lasting change in the growth rate 
of the treated cells once they are returned to control media after 7 days of growth in the 
treated media. Further studies are warranted to quantify the mechanisms to explain this 
observed phenomena. 
 
We conducted an experiment where the MDA-MB231 cells were grown in treated 
and control media for 8 days. At the end of the 8th day, the treated cells were placed back 
in control media to see if the growth rate would correspond to the original growth rate 
that occurred in days 1-8. The 95% confidence intervals were used to analyze the groups 
and there was a significant difference in growth rates between the control and treated 
cells when the cells had been growing in treated media for 8 days. The treated cells also 
appear to continue to grow more slowly than the control with no rebound once they are 
placed back in control media at day 8 (Figure 13). 
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Figure 10. MDA-MB231 Fluorescent Microscopy with Annexin Staining. 
Control (left) Treated (right). 
 
 
 
 
 
 
Figure 11. MDA-MB231 Cells Phase Contrast Microscopy. 
Control (left) Treated (right). 
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Figure 12. MDA-MB231 Cells Treated 14 Days versus Treated 14 Days and 
Placed in Standard DMEM for 14 Days. 
Treated 14 days (left) Treated 14 days and placed back in standard media (right). 
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Figure 13. MDA-MB231 Control and Treated Cells Grown in Control and 
Treated Media for 7 Days and then Both Groups Placed in Control Media on Day 8. 
Data were analyzed with GLM of SAS 9.4. The data were divided into 4 groups 
analyzing cell growth/time. The slopes and 95 CI % within the treatment period were 
analyzed. These 4 groups were analyzed: B11- control cell growth from day 1-8 (blue); 
B12-control cell growth from day 8-12 (blue); B21-treated cell growth from day1-8 
(yellow); B22-treated cell growth back in control media from day 8-14 (yellow). After 
analyzing 95 CI %, we found that B11=B12 and these two slopes showed continuous 
growth. We also found that B22 < B21 which suggests that there was no rebound in 
growth of the treated cells when placed back in control media on day 8 and in fact there 
was a reduced growth which suggests a reduced growth rate in these cells after grown in 
treated media. When we compared B22 to B11, there was no overlapping of confidence 
intervals between the two groups suggesting there was a significantly reduced rate of 
growth in B22 when compared to B11. 
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Differential Effects on the Recovered RNA and Protein Levels of Cancerous Cells 
 
When conducting our microarray analysis on the MDA-MB231 cells grown in the 
treated media for 3 days, we noted there was a significant increase in RNA in the treated 
groups when compared to control (Figure 14). We then conducted an assay to determine 
if this increase in RNA corresponded to an increase in protein production as well in the 
treated cells. Upon analysis of the BCA protein data, paired t-tests showed no significant 
difference in the protein content between the treated and control groups of MDA-MB231 
cells after being grown in the treated media for 3 days (p = 0.71126). The control group 
did show a slight increase in protein content over the treated groups although not declared 
significant (Figure 15). 
 
 
Differential Effects on mRNA Expression per Affymetrix 2.0 Microarray 
 
 Due to the significant effects that were seen in cell growth/proliferation, cell 
cycle, membrane potential, and tubulin assay; Affymetrix 2.0 microarray analyses were 
conducted on both the human breast carcinoma cell line and the human breast epithelial 
cell in order to see what, if any, effects on gene expression could be measured. Data were 
normalized using the RMA Sketch Global normalization function in an Affymetrix 
expression console and analyzed with QIAGEN’S Ingenuity Pathway Analysis (IPA) to 
identify relationships, mechanisms, functions and pathways of relevance in the data. 
Results of this analysis indicated that the treated group of the carcinoma cell line 
displayed a significant upregulation in pathways of the Unfolded Protein Response 
(UPR), Phenylethylamine Degradation 1, tRNA charging and Serine and Glycine 
Biosynthesis. Strong changes were also displayed in the upstream regulators of TRIB3, 
PPRC1, ATF4, SCD and GNE. The expression of over 1,000 genes showed a 2- 18 fold 
change after growth in the treated media compared to cells grown in the control media. 
The significant changes in gene expression that were upregulated in the treated group of 
the cancerous cells were in the areas of cell survival/death, cell cycle progression, 
immune modulation and membrane potential. Endoplasmic r eticulum (ER) stress leads 
to a compensatory mechanism in cells referred to as the Unfolded Protein Response 
(UPR). The UPR is a cellular stress response that is related to ER stress and has been 
known to be conserved in all mammalian species (Figure 16).46 The UPR shows 
significant upregulation in these three arms that are used when the UPR is initiated in 
order to restore function in the cell: 1) halting protein translation (see PERK-ERN1) 2) 
degradation of the misfolded proteins (see EDEM2/ERO1-LB) 3) activation of signaling 
pathways that lead to soliciting the help of molecular chaperones that are involved in 
protein folding (IRE1, XBP1).46 The UPR also shows an upregulation in the apoptosis or 
programmed cell death (CHOP/DDIT3/CHAC1) arm. Therefore, the microarray analysis 
diagram below (Figure 16) shows significant upregulation (purple highlights) in all three 
arms of the UPR and in the stress response leading to apoptosis of the MDA-MB231 
cells. Finally, GADD34 (see below) is a CG3825 gene product from transcript CG3825-
RA that binds to PP1 and facilitates translational elongation of specific transcriptional 
factors that lead to phosphorylation of eIF2-a, thereby terminating global protein 
translation and inducing apoptosis.54 There was also a down regulation in many cell cycle  
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Figure 14. RNA Recovered from Treated versus Control MDA-MB231 Cells. 
 
 
 
 
 
 
Figure 15. BCA Protein Analysis. 
BCA protein analysis showing difference in the protein concentration at 0.2 mg/ml 
dilution of MDA-MB231 cells when grown in control and treated media for three days - 
Unpaired t-tests - Control mean 0.248; Treated mean 0.231; ts- 0.380879; df- 10; p = 
0.71126. This shows no signficant difference in protein conentrations but does suggest a 
slight decrease in the treated protein concentration when compared to control. 
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Figure 16. ER Stress/Unfolded Protein Response. 
Data were analyzed through the use of QIAGEN’s Ingenuity® Pathway Analysis (IPA®, 
QIAGEN Redwood City, www.qiagen.com/ingenuity). 
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progression genes with an upregulation in many genes in the p53 pathway. Significant 
changes also occurred with an upregulation in the tumor necrosis factors (TNF) as well in 
the immune responses of several cytokines. 
 
The MCF-10A cell line microarray showed an up regulation in the pathways of: 
Superpathway of Serine and Glycine Biosynthesis I, Serine Biosynthesis, Role of IL-7A 
and Granulocyte Adhesions and Diapedesis. While the microarray did show a significant 
fold increased in the ER Stress and Unfolded Protein Response pathways in the MDA-
MB231 cells, it did not show an increased fold change ER Stress or the Unfolded Protein 
Response in the MCF-10A cells. There was an 8-fold decrease in the CHAC1 expression 
and this had been shown to correspond to a reversal in ER stress/UPR.106 The MCF10A 
cells did not show a down regulation of cell cycle progression. There was a greater 
increase in immune cytokines in the MCF-10A cells when compared to the MDA-MB231 
cells. While the MDA-MB231 cells showed a significant fold change in the upregulation 
of the p53 pathway, there was no up regulation in the tumor necrosis factors or the p53 
pathway in the MCF-10A cells. Two heat maps were generated to show both the 
microarray data and the real time PCR validations (Figures 17 and 18). A list of the gene 
expressions for both the treated and control groups in both cell lines that were evaluated 
and validated in order to make biological correlations to our experimental data are listed 
in Table 3. 
 
 
Validation of Differential Gene Expression by RT-qPCR of Cancerous and 
Noncancerous Cells 
 
Once all primers were tested for appropriate efficiency of 1.8-2.1 (Figure 19) 
based on conformity of the standard deviations of all of the dilutions, cDNA was made 
from 5 biological control samples of the MDA-MB231 cells and 5 biological treated 
samples of the MCF-10A cells using the Transcriptor First Strand cDNA Synthesis Kit. 
 
The RNA and all the above listed reagents were then placed in a thermal block 
LightCycler 480 instrument with a heated lid and run through the 60 minute cycled 
experimental program for denaturation, amplification, melting and cooling. The cDNA 
was placed in a -80C freezer until use for real-time qPCR. 
 
Real-time qPCR for each gene was run in triplicate for each of the 5 control and 5 
treated biological samples. Relative quantification was used to analyze the changes in the 
gene expression in the samples relative to the reference sample that was analyzed from 
each of the biological replicates. Amplification curves were noted on all the gene samples 
(Figure 20) and each sample was run in triplicate (Figure 21). 
 
The ER Stress/UPR pathway genes of: ERN1, HERPUD1, XBP1, DDIT3 and 
CHAC1 all showed a significant increase in gene expression in the treated MDA-MB231 
cells. The ER Stress/UPR showed no up regulation in the MCF-10A by validation of 
DDIT3.  The CHAC1 gene in treated MDA-MB231 cells showed a 256-fold increase 
which shows a strong response in the apoptotic arm of the UPR after 3 days in the treated  
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Figure 17. Heat Map from Affymetrix 2.0 Gene Expression Values. 
(See Table 3) Values related to ER stress/UPR, immune/TNF, cell cycle, tumor targets, 
cell death and membrane potential across the four conditions of the control and treated of 
the MDA-MB231 and MCF-10A cell lines. 
 
 
 
 
 
 
Figure 18. Heat Map of Genes Validated with RT-qPCR. 
TP53INP1, JMY, CASP4, ERN1, TNFRSF9, CHAC1, CLIC4, DDIT3, HERPUDI, 
EROL1B, EDEM2, XBP1, ATF4, CCNE2 and HMMR.  
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Table 3. Normalized Affymetrix 2.0 Gene Expression Levels of MDA-MB231 
and MCF-10A Cells for ER Stress/UPR, Immune/TNF, Cell Cycle, Tumor Targets, 
Cell Death and Membrane Potential. 
 
Gene MDA-MB231 
Control 
Expression 
MDA-MB231 
Treated 
Expression 
MCF-10A 
Control 
Expression 
MCF-10A 
Treated 
Expression 
DDIT3 92.20325 604.7977 74.5718 38.54762 
FBXW10 17.46405 81.63718 12.86469 19.93201 
ERN1 167.6198 1715.344 180.1033 177.2253 
CHAC1 208.6184 3336.654 224.6349 67.11283 
CBLB 300.1236 1641.758 293.6763 254.1021 
HERPUD1 1783.141 5490.769 1948.906 1336.873 
FAM129A 885.9388 2438.941 164.713 43.46248 
ATF4 1885.499 3100.368 884.2608 612.7664 
XBP1 1657.966 3991.217 646.7754 396.2133 
TBC1D3H 302.5868 707.418 295.0598 210.7293 
SEL1L 1245.15 2877.084 1030.507 742.8039 
EDEM2 346.4626 758.4768 246.9249 121.0007 
EROL1B 198.7048 356.374 166.5647 130.24 
PP1R15A 621.7018 2642.331 445.151 518.1046 
GADD45A 206.6781 855.5336 669.77 766.9318 
TP53INP1 92.76067 267.6483 458.6459 322.1881 
DRAM1 678.105 1709.15 301.5608 301.5608 
PRSC1 573.9486 159.1545 89.98862 65.02022 
GTSE1 1697.772 476.1245 149.0838 150.521 
JMY 240.5889 1179.91 483.9303 433.1115 
IL1A 50.914898 682.6169 3773.235 6656.809 
SPHK1 224.5578 542.8292 74.35 84.3 
IL8 135.5218 542.5673 285.7594 689.56 
IL20Rb 216.931 855.3889 2492.348 2037.954 
TNFS4 38.17249 104.0848 31.551 29.38311 
TNFRSF10 1322.594 2931.227 679.15 354.5 
IL21R 88.24291 186.0786 34.35 34.02 
TRIB3 578.2565 2925.584 534.79 197.3 
IL13RA2 268.6343 714.5335 10.6687 15.999 
OSMR 1435.055 3519.421 1430.7 1591.7 
ABBC3 265.6539 648.5226 1368.9 1353.1 
TNFRSF9 130.5561 1854.911 45.3355 33.309 
IFi30 3007.301 826.8794 1181.883 1707.668 
CCNE2 1550.488 156.7187 45.6 31.78 
HIST1H2BB 1454.32 176.3751 43.2 68.3 
HIST1H2BM 9383.078 904.6331 1089.2 673.5 
HIST1H2AB 206.6644 31.26837 16.4 15.1 
HIST1H3H 182.1673 33.49529 47.7 106.8 
HIST1H2AJ 49.123 11.901 8.85 9.54 
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Table 3. Continued. 
 
Gene MDA-MB231 
Control 
Expression 
MDA-MB231 
Treated 
Expression 
MCF-10A 
Control 
Expression 
MCF-10A 
Treated 
Expression 
HIST1H4B 450.5416 113.0835 22.25 18.6 
HIST1H2AM 167.8033 42.64463 22.93 16.9 
HIST1H3B 204.3861 58.02624 11.73 6.98 
HIST1H4A 219.4193 62.61253 21.9 15.2 
HIST1H2BL 180.3614 54.36535 164.2 93.9 
CASC5 2899.345 956.1502 485.2 499.3 
HIST2H3D 139.2912 45.06532 79.91 59.5 
HIST2H2AB 4406.727 1618.736 1337.66 491.5 
CDCA7 114.252 158.884 135.68 139 
CDCA3 690.5287 128.4345 85.279 66.4689 
MCM10 2026.938 409.4398 146.7 95.14 
E2F8 1701.76 344.8467 93.04 67.344 
CENP1 1211.37 248.7287 206.29 126.7361 
DSCC1 1055.73 227.4702 136.52 53.78 
CCNA2 3625.114 813.5735 789.6391 715.2556 
CDKN2C 529.6627 118.9669 86.3 77.336 
LMNB1 105.6866 23.76363 170.453 117.7738 
CHAF1B 1302.628 306.5765 266.99 156.226 
PCNA 3565.479 859.501 708.95 627.721 
CENPE 1585.373 386.5323 384.29 280.6339 
SPC25 973.4363 237.5617 68.93 54.43 
CLSPN 257.1571 63.77828 45.25 46.39 
MYBL2 663.0643 175.7511 162.5156 195.258 
MAD2L1 2916.937 761.4398 261.8003 146.9315 
CDCA2 1287.288 343.2617 277.99 314.51 
CDC45 2032.203 546.5767 194.04 135.39 
DLGAP5 3326.605 918.2717 294.9 322.08 
SKP2 4475.243 1275.213 1584.21 1247.42 
GRPR 462.8514 132.1584 23.264 19.78769 
KIF23 3014.659 1006.878 458.2247 432.4457 
KIF15 1047.023 351.514 210.2767 146.1035 
CDK1 1191.199 418.2505 302.653 219.0567 
CDKN3 2829.865 818.9569 558.78 441.95 
ORC1 787.6633 228.1306 138.7296 108.0838 
KIF20B 1491.5 485.3235 479.7726 370.89 
CCNB1 1460.134 437.5147 394.2499 414.196 
PLK1 7734.812 2320.248 2193.42 1800.224 
CDC20 4119.106 1241.424 1542.313 1298.382 
TTK 2063.557 623.2984 404.7908 388.5892 
SGOL1 2204.15 680.1693 357.85 353.49 
CENPK 965.4617 298.0388 117.869 86.63 
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Table 3. Continued. 
 
Gene MDA-MB231 
Control 
Expression 
MDA-MB231 
Treated 
Expression 
MCF-10A 
Control 
Expression 
MCF-10A 
Treated 
Expression 
CDK15 597.6559 187.5154 25.435 22.931 
OIP5 656.4835 210.1888 108.08 65.89 
PRC1 3544.327 1135.643 626.4265 457.0201 
AURKA 1372.692 441.3315 241.9177 182.5047 
DNA2 680.8584 220.6961 158.5015 128.2752 
PLK4 740.555 241.9631 118.182 81.45791 
MCMY 1946.111 754.5332 316.8071 318.7342 
FOXM1 2150.082 834.0797 453.6553 534.8372 
CENPO 1545.834 528.9465 173.4009 134.9089 
CDC25A 906.8274 355.5253 81.97407 73.47563 
KIF4A 1226.718 483.1996 285.4267 325.8651 
BORA 833.334 333.975 177.7702 161.6121 
PRIM1 1933.796 639.5529 289.6865 144.092 
KIF23 3014.659 1006.878 458.2247 432.4457 
BUB1 3482.412 1171.759 535.3447 538.2644 
NUF2 1068.651 362.4769 158.0058 117.314 
CENPA 1604.808 623.0319 259.9626 173.262 
NEK2 1471.66 508.0363 798.9699 809.4927 
CDC25C 559.6721 194.3788 150.2855 97.89624 
CDK15 597.6559 187.5154 25.436 22.93094 
CIT 708.1124 251.2761 290.004 225.4576 
CCNF 509.6929 181.4399 143.653 115.1559 
CDCA8 2367.439 856.6898 532.59 448.22 
ASF1B 3257.62 1238.113 417.605 193.1282 
CENPL 407.7961 156.0273 124.78 103.6942 
CCNA1 1235.768 475.7696 132.0476 199.9614 
CENPM 559.2139 212.9774 116.38 91.68 
KIF11 3238.945 939.4666 708.69 495.69 
CDC45 2032.203 546.5767 194.04 135.38 
CENPF 1518.461 633.5304 1067.66 1123.12 
CASP4 78.27916 167.4708 99.7621 93.61928 
CASP6 315.9396 153.2165 110.2821 103.9024 
UNC5B 165.5258 1028.606 765.4645 432.6196 
CARS 410.5192 1051.12 212.4383 107.2973 
BEX2 54.2207 128.0799 39.484 39.164 
JUNB 700.5781 1589.828 1304.435 1068.991 
HMMR 681.7925 183.141 504.2788 362.3813 
PTTG1 267.0026 72.87782 45.128 40.01671 
FANCA 907.874 292.4976 196.06 128.35 
TGFB2 2404.895 897.6522 212.696 258.4106 
FAM83D 2544.584 698.6316 700.476 661.334 
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Table 3. Continued. 
 
Gene MDA-MB231 
Control 
Expression 
MDA-MB231 
Treated 
Expression 
MCF-10A 
Control 
Expression 
MCF-10A 
Treated 
Expression 
KIFC1 1314.23 428.6075 179.392 145.62 
E2F1 2050.937 671.5983 108.8849 92.29729 
CLIC4 2043.479 5258.273 2021.464 1791.211 
CLIC2 57.95258 117.7829 345.69 274.86 
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Figure 19. Primer Testing for TNFRSF9. 
All primers were designed and then tested on cDNA from MDA-MB231 cells. This 
shows the amplification curves of the 5 different dilutions used for TNFRSF9. The 
expression values for each dilution are plotted on a standard curve. An efficiency is 
determined based on the slope and y intercept. An efficiency of 1.8-2.1 is required for 
each primer prior to validation experiments. Each of the primers were designed for each 
gene and taken through efficiency testing prior to real time qPCR validation on the genes 
of interest. 
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Figure 20. Amplification Curves of Fluorescence over Cycles for Real Time 
qPCR with Triplicate Testing of Gene Expression on a 96 Well Plate when 
Comparing Control and Treated Gene Expression Levels of MDA-MB231 Cells. 
The fluorescence occurs using TaqMan probes that become degraded by Taq polymerase 
and releases the fluorophore thereby relieving the quenching effect. The fluorescence 
detected in the quantitative PCR thermal cycler is directly proportional to the fluorophore 
released and the amount of DNA template present in the qPCR. 
 
 
 
 
 
 
Figure 21. Amplification Curve - RiboS19. 
Amplification curves in triplicate of housekeeping gene used for extrapolation of control 
and treated data for real time qPCR.  
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media, but was significantly down regulated in the MCF-10A cells.39 The TNFRSF9 gene 
showed a 128-fold increase in a player in the TNF/TRAIL pathway. TNFRSF9 has been 
shown to be expressed in activated T cells (CD8 & CD4), dendritic cells, natural killer 
cells, granulocytes and blood vessel inflammation.100It has also been shown to stop 
tumors in mice.107 The Junction Mediating Protein (JMY) is a p53 cofactor that codes a 
tumor suppressor protein and is up regulated 4-fold in our validations. It is believed to be 
a key transcriptional regulator and controls DNA repair, cell cycle progression, 
angiogenesis and apoptosis.101The loss of p53 function is thought to be a contributing 
factor in the majority of cancer cases. Caspase 4 (CASP4) is the caspase that is linked to 
ER Stress/UPR and it is up regulated 8-fold.102 Cyclin E2 (CCNE2) is down regulated 
32-fold and has been shown to be elevated in tumor-derived cells and plays a role in the 
G1/S transition in the cell cycle.103 Hyaluronan-mediated motility receptor (HMMR) 
interacts with BRCA1and other proteins to control key aspects of cell polarity and cell 
division and may hold answers to how to treat women with BRCA1 and BRCA2 
mutations as its expression and overexpression has been linked to ras transformation, 
tumor progression and metastasis.104 HMMR is down regulated 16-fold on our 
validations. Chloride Intracellular Channel 4 (CLIC4) is a group of proteins who regulate 
cell membrane potential, transepithelial support, maintain pH and cell volume. Under 
expression or reduced CLIC4 alters the redox state of tumor cells and enhances tumor 
development.105 It is upregulated 8-fold in our gene validations (Figure 22). Unpaired t-
tests were conducted on MDA-MB231 and MCF-10A gene validations (Table 4). 
 
 
DISCUSSION 
 
The initial cell growth studies found significant growth inhibition of the B16 
murine melanoma and the MDA-MB231 human breast carcinoma while failing to show a 
growth inhibitory effect on the L929 mice fibroblasts and the MCF-10A breast epithelial 
cells. We conducted various experiments to see how long and under what conditions 
these effects were noted. The treated water alone appears to retain the ability to reduce 
cell proliferation of cancerous cells for up to 21 days. Once the treated water is combined 
with the components to make the growth media, the treated hypotonic saline solution 
appears to lose its effects on day 5 or 6 since cancerous cells were observed to show a 
significant increase in cell growth/proliferation at this time point. A possible explanation 
for this can be hypothesized and is discussed extensively in chapter 4. The treated water 
appears to retain the effect created by treatment with the CETS system for a longer time 
period (21 days), as shown by growth inhibitory effects of cancerous cells when grown in 
media made with stored treated water, than does the treated growth media once it is made 
with the treated water as shown by the effect waning on day 5-6. This addition of other 
molecules/ions to the media could in effect, nullify or change the effects induced by the 
CETS system once added due to molecular changing/bonding that occurs between the 
various ions contained in the water and ions added with the growth media contents. 
 
The cancerous cells also began to show a microscopic change of ‘rounding up’ 
after they were growing in the treated media for several days. The growth inhibitory 
effects and the ‘rounding up’ led us to cell cycle analyses, where we noted the cell cycle  
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Figure 22. RT-qPCR Fold Change. 
 
 
 
 
Table 4. Unpaired t-Tests of RT-qPCR. 
 
Gene 
 Unpaired t-Tests    
 df ts p  Mean/Control Mean/Treated 
MDA-MB231     
CHAC1  8 26.796 .000000004  13.26134 6.184 
HERPUD1  8 7.72534 .0000561  7.53 5.1 
EDEM2  8 1.1876 .269047  9.3 9.8 
XBP1  8 12.7308 .00000136  5.74 4.34 
TNFRSF9  8 26.7993 .0000000004  13.55 8.05 
JMY  8 25.3296 .000000000682  9.7 7.4 
CCNE2  8 7.79364 .000108  6.24 10.74 
HMMR  8 6.38892 .000212  6.744648 10.32 
DDIT3  8 8.75038 .0000228  11.23 9.53 
CASP4  8 7.6846 .0000583  8.214653 5.63 
CLIC4  8 11.0548 .000004  5.17264 3.106 
MCF-10A     
DDIT3  8 0.05804 .955142  12.668 12.678 
CHAC1  8 12.0055 .00000214  13.00 16.7 
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arrest in the cancerous cells while the noncancerous cell lines, showed no change in the 
cell cycle in either the treated or control groups. We then proceeded to conduct the 
Annexin V-FITC Apoptosis assay on the cancerous cell lines where we were unable to 
quantify any differences between the stained and unstained treated groups due to an 
autofluorescence that was induced in all the treated cells when analyzing by flow 
cytometry. We then conducted fluorescence microscopy on the treated and control 
cancerous cells and could visualize the green fluorescence associated with annexin 
staining. This observation suggests the binding of the Annexin staining to 
phosphatidylserine and the early stages of apoptosis in the cancerous cells that had been 
grown for 3 days in treated media. The green fluorescence was not seen on fluorescent 
microscopy with the control cancerous cells which suggests the control cancerous cells 
were not undergoing apoptosis. 
 
Due to the Vmem differences in cancerous and noncancerous cells, we decided to 
conduct membrane potential assays to determine if the treated media was causing a 
change in the membrane potential of the cells. The membrane potential findings suggest 
that the cells are initially hyperpolarized by exposure to the treated media and then begin 
to depolarize within the first 8 hours. By 24 hours the noncancerous cells have returned to 
their original baselines but the cancerous cells stay at a more polarized level than their 
original baseline. The CLIC4 gene is known to participate in membrane potential 
regulation and is a known tumor suppressor.105 CLIC4 is upregulated 4-fold in the treated 
MDA-MB231 cells in the RT-qPCR validation but was not upregulated in the 
noncancerous cells. This genomic change in expression in a gene in the cancerous cells 
that controls membrane potential regulation corresponds to the membrane potential assay 
testing. This suggests the treated media shows an effect in the regulation of membrane 
potential in cancerous cells who are known to possess a depolarized membrane when 
compared to a noncancerous cell.   
 
The microarray and RT-qPCR validations on the MDA-MB231 cells showed the 
unfolded protein response (UPR) as the top pathway affected significantly by the CETS 
unit and this pathway was not upregulated in the microarray and the RT-qPCR of the 
MCF-10A cells. The UPR is a series of signaling events that occur due to intracellular 
stress from misfolded proteins in the lumen of the endoplasmic reticulum (ER).  Certain 
pathologic stimuli can cause an interruption in the protein folding process and these 
include but are not limited to: calcium depletion, altered glycosylation, nutrient 
deprivation, oxidative stress, DNA damage or energy fluctuations.38 While no significant 
increase in protein synthesis was found with the BCA protein assay of human breast 
carcinoma, data showed a 2.5 fold increase in mRNA between the treated and control 
groups.  The increase in mRNA indicates a possible increase in transcriptional affects 
may be initially occurring prior to the up regulation of ER stress/UPR pathways. The cell 
size appears to increase initially in our cell size data and the cells then begin to shrink 
which could suggest the halting of protein synthesis and the ER degradation/protein 
degradation that occurs with the UPR survival response. UPR has been shown to be 
activated by increased activation of ATF4 and increased transcription of its target C/EBP 
homologous protein (CHOP), which is a pro-apoptotic factor.37 ATF4 is a strong 
upstream regulator in our microarray analysis. The known causes of UPR are energy 
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fluctuations. This suggests a possible connection between the significant changes in the 
membrane potential of the cancerous cell lines and the upregulation of the UPR. The 
treated media did not illicit a growth inhibition in the noncancerous cells, which shows 
that growth arrest from UPR is likely not occurring in the noncancerous cells and also 
lends to the thought that other known causes of ER stress related to nutrient or calcium 
deprivation from the media are most probably not originating factors in the cancerous cell 
lines. The RT-qPCR validated that ER Stress/UPR gene expression was not up regulated 
and this corresponds to the experimental findings with the MCF-10A cells. The cell 
growth studies found cancerous cell lines significantly slowed mitosis and halted their 
cell cycles. In ER stress there is a struggle to balance adaptation and alarm/death. UPR is 
often highly activated in cancer cell to promote survival. In the RT-qPCR validations, 
ERN1 is upregulated 14-fold, which could suggest one mechanism for cell cycle arrest 
and DDIT3 (CHOP) is upregulated 4-fold, while CHAC1, which is downstream from 
CHOP is strongly upregulated 256-fold and could indicate that these cancer cells are 
headed down the apoptosis arm of the UPR after 3 days of exposure to the treated 
media.51 CHAC1 is the pro-apoptotic component of the unfolded protein response 
pathway that mediates the pro-apoptotic effects of the ATF4-ATF3-DDIT3-CHOP 
cascade.39  Caspase 4 was significantly upregulated 4-fold as well in the RT-qPCR and 
this is the caspase that is linked to the UPR and could suggest a possible beginning to a 
cell death.49 An unsuccessful UPR can also be caused by an increase in TNF, which was 
also significantly upregulated 126-fold in the RT-qPCR and operates down the IRE1-
TRAF2-JNK pathway in ER stress.47 TRIB3 was shown to be a significant upstream 
regulator in our microarray, which is a known sensitizer of cells to TNF and TRAIL 
induced apoptosis.55 
 
In our microarray, TP53INP1 is significantly upregulated gene that is involved in 
making a protein that has anti-proliferative and pro-apoptotic properties and acts as a 
regulator of transcription and autophagy. This gene plays a major role in the p53/TP53 
oxidative stress response and was also validated with RT-qPCR as a 4-fold increase with 
JMY. It is possible that ER stress/degradation and anything that leads to the UPR could 
nonspecifically halt DNA replication leading to p53 activation and apoptosis.41,43 
TP53INP1 can also reduce cell migration by regulating the expression of SPARC.44 
 
The microarray found that TNFRSF9 was also found to be significantly 
upregulated downstream from the also significantly affected ER transmembrane protein: 
Inositol Requiring 1 (IRE1). Prolonged ER stress has been shown to activate the pro-
apoptotic IRE1-TRAF2-JNK pathway. Tumor necrosis factor receptor superfamily, 
member 9 is a member of the TNF receptor superfamily that is implicated in the survival 
and development of T cells. It is a significant player in the 4-1BB Signaling in T 
lymphocytes pathway, which is known for eradication of established tumors, enhancing 
integrin-mediated cell adhesion and increasing T cell cytolytic potential. TNFRSF9 is 
also linked to the Death Receptor Signaling and NF-KB pathways.42 Even though tumor 
necrosis factors are not playing a role in these in vitro experiments, they could be a strong 
player in a future in vivo model. Also, CLIC4 codes for a diverse group of proteins that 
regulates cellular processes, such as stabilization of cell membrane potential. CLIC4 has 
been shown to participate in suppression of tumor growth and the absence of decreased 
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levels of CLIC4 has been found to contribute to TGF-B resistance and enhances tumor 
development.45 Membrane potential assay results correlate with this finding. These 
significant changes of CHOP, CHAC1, JMY/P53, and CASP4 in the microarray/RT-
PCR, Annexin V fluorescent microscopy and the noted microscopic effects of nuclear 
fragmentation, blebbing and decrease in cell size suggest a possible apoptosis or other 
form of undetermined cell death may be occurring in these treated human breast 
carcinoma. Interestingly, the MCF-10A cell line did not show these experimental or 
genomic effects and show this could be a possible side-effect free adjunct therapy for 
cancer patients. More funding and research is needed to verify what is occurring in these 
cells. 
 
 
CONCLUSION 
 
Understanding how energy fluctuations can contribute to UPR and other genomic 
signaling offers a new opportunity to exploit the programmed balance of survival and cell 
death in order to catapult the cancerous cells past levels compatible with survival. 
Combining chemotherapeutic and pharmacologic treatments with this potentially known 
ER stressor from hyperpolarization in cancerous cells can potentially augment cell death 
and increase chemotherapeutic efficacy. Chemotherapeutic agents that cause ER stress 
such as brefeldin A, Velcade and geldanamycin, could be effective in enhancing UPR in 
order to promote apoptosis in cancer cells.40 To obtain ER homeostasis, eukaryotic cells 
have developed or evolved the UPR in order to have an adaptive intracellular signaling 
pathway that is essential when a response to metabolic stress, oxidative stress, 
inflammation, neurodegenerative disease or cancer is needed. UPR is a survival 
mechanism that is often used by cancerous cells. Could the hyperpolarization of the cell 
membrane in these cancer cells lead to an ER stress induced UPR that becomes too 
challenging for these cancer cells to overcome leading to a transition from the 
adaptive/protective stage to the pro-apoptotic/pro-death stage? The microarray and RT-
PCR validations show the cancer cells heading down several pro-apoptotic pathways 
related to ER stress/degradation, as well as the p53 oncogene activation pathway while 
these validations also show this effect is not occurring in the noncancerous cells. The 
mechanism of triggering p53 signaling during ER stress induced apoptosis is currently 
unknown but may possibly be associated with a hyperpolarized membrane according to 
both our experimental findings and the genomic analyses. Two of the top pathways 
delineated in our microarray according to our Ingenuity analysis were also shown to be 
serine biosynthesis and the super pathways of serine and glycine biosynthesis. The tumor 
suppressor p53 has been classically known to regulate DNA repair, cell-cycle arrest and 
apoptosis. In the process, these actions will upregulate metabolic targets and thereby 
upregulate these pathways of biosynthesis.52 The upregulation of serine and glycine 
biosynthesis is an essential reversal of how cancer cells can usually reprogram their 
metabolism by shifting from oxidative phosphorylation to aerobic glycolysis (Warburg 
effect) in order to achieve unchecked growth.53 The amplification of metabolic enzymes 
has been found in breast, liver, prostate and melanoma cancers due to the identified 
amplification of the gene encoding phosphoglycerate dehydrogenase (PHGDH) leading 
to increase flux through the serine/glycine pathway.60 PHGDH increase has been linked 
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to increased proliferation of cancerous cell lines.60 Our data suggest an increase in 
PHGDH and the serine/glycine super-pathways can also be possibly linked to decreased 
proliferation in cancerous cells lines under the right conditions, while conversely, this 
pathway was also upregulated in our noncancerous cell line, which did not show a halt in 
cell cycle or cell growth. In recent years, the study of metabolism has returned to the 
forefront of cancer research. Data now support that altered metabolism can possibly 
result from the reprogramming by altered oncogenes and tumor suppressors. Our data 
suggest that restoring the altered oncogene and tumor suppressor functions could return 
the cell to a normal metabolism. Altered metabolism as well as an altered immune 
response should continue to be considered two major hallmarks of cancer that is studied 
in future research. 
 
Could hyperpolarization of the cell membrane hold the key to unlocking multiple 
mechanisms that lead to cancerous cells cell cycle arrest, increasing and then the 
abandoning of the UPR as a survival mechanism, becoming sensitized to TNF and 
TRAIL activation, and activation of p53, thereby causing eventual apoptosis or another 
type of cell death, while not illiciting the same response in a noncancerous cell? The 
cancer cells appear to have increased anabolic function with the upregulation of the 
serine/glycine super pathways (nucleotide formation), increased catabolic function with 
the upregulation of phenylethylamine degradation pathway (carbon and nitrogen source) 
and reprogramming of the UPR and p53 genomic apoptotic mechanisms. There are many 
forms of cell death that include but are not limited to apoptosis, entosis, mitotic 
catastrophe, necrosis, necroptosis, excitotoxicity, autophagic cell death, and pyrotosis.61 
Dying cells are engaged in a process that is reversible until a “point of no return” is 
passed.61 The MDA-MB231 cells appear to be headed down a cell death pathway, while 
the MCF-10A cells do not. The cancerous cells that appear to survive the exposure to the 
treated media also appear to display different characteristics of slower cell growth when 
placed back in standard/non-treated media (Figure 13). This slower cell growth could 
suggest some form of change in cell metabolism/function. Many other associated gene 
expressions that are linked to control of tumorigenesis, tumor development, cell 
migration and cell differentiation have been shown significant in our microarray and 
warrant more research. The upregulation of IL1A (IL10) and TNF also have been linked 
to an unsuccessful UPR and could also lead to research in the autoimmune response to 
disease. There are also strong down regulatory changes that are linked to cell cycle check 
points as well as cell cycle progression. Hyperpolarization of the plasma membrane could 
in theory be a reprogramming of a cancer cell to behave like a normal cell that has lost its 
ability to function as a beneficial member to the organism; whereas a cell cycle arrest and 
eventual cell death cascade is initiated. Hyperpolarization of the noncancerous cell line 
does not appear to similarly affect these same pathways. There appears to be a slight 
down regulation of the ER Stress/UPR pathway, which could show promise for other 
chronic diseases such as neuro-generative diseases, organ fibrosis and diabetes that have 
also been linked to an aberrant UPR. There is a significant differential effect with regards 
to ER Stress/UPR and many other metabolic functions of the cell with the CETS treated 
water when one compares the cancerous cell versus noncancerous cell line responses. 
More research is warranted to further verify and validate these observed effects. 
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CHAPTER 3.    HYPERPOLARIZATION OF PLASMA MEMBRANE 
ENHANCES WOUND HEALING  
 
 
INTRODUCTION 
 
Wound healing is a critical process that, if impaired, can increase the risk for 
infections, complications, patient discomfort and slow the return to activities of daily 
living. Many of the biological mechanisms that both drive and prevent chronic wound 
healing are poorly understood.16,63 Cell migration plays a key role in both the spread of 
cancer cells and in wound repair. Some acute wounds are known to heal quicker with 
electric stimulation such as is used in orthopedics and sports medicine where an electrical 
signal can lead to an upregulation of cartilage matrix protein production and nitric oxide 
dependent chondrocyte proliferation from a bone growth stimulator.64,67 On the contrary, 
chronic non-healing wounds that occur with diabetes, malnutrition, infection, chronic 
inflammation and aging currently have no effective therapy available and treatment for 
the biological impediments remain elusive.62 Thus, chronic wound care generates a very 
challenging and significant economic burden to our health care system.68 
 
One hundred and sixty years ago, Du-Bois Reymond, founder of 
electrophysiology, identified electromagnetic fields on a hand wound.68 Electromagnetic 
fields were recently shown to activate multiple signaling pathways that are instrumental 
in wound healing. Unlike other wound treatments, electromagnetic fields have the 
intrinsic property of being directional (polarized).9,14 Cell migration 
(electrotaxis/galvanotaxis) appears to be driven by electromagnetic induced polarized 
signaling of epidermal growth factor receptors, integrins, and phosphoinositide 3 
kinase/Pten, and some research also points to involvement of protein kinase C, 
intracellular calcium, and cyclic adenosine monophosphate.63  Electromagnetic fields 
have also been found to override other signaling cues of cell migration such as: 
chemoattractant gradients, injury stimulation, contact inhibition, wound void and 
population pressure.65,66,2 When an electromagnetic field of physiological strength is 
applied in the opposite direction of these signaling cues, cell migration begins to follow 
the direction of the electromagnetic field.63  Plasma membrane potential (Vmem) 
differences have been found in injured and proliferating cells.12,13 Injured and 
proliferating cells have a measurable depolarized membrane potential of approximately < 
-30mV, while healthy and non-proliferating cells have a resting potential of 
approximately > -70mV.12,17 Cells have been shown to respond to different 
electromagnetic signals when undergoing division, migration and differentiation.63 It has 
been found that magnetic fields involve the changing gradients of Vmem that are 
produced and sensed by non-excitable cells in living organisms.17,18 Therefore, 
bioelectricity shows an effect well beyond excitable cells and has been shown to affect 
wound healing, cell migration, nerve growth and limb regeneration.3,4,24 
 
Previous basic and clinical electromagnetic therapy wound care research has 
historically been conducted with a vibrating probe technique that places a flow of 
positive charge directed toward the wound both in vitro and in vivo. This probe technique 
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has shown great promise with affecting not only the motility of the cells but also the 
directional migration of the cells in vitro.63 Impaired cell migration is characteristic of 
chronic wounds and in order to heal, cells must migrate directionally and in an organized 
fashion.65 Unfortunately, extrapolation and translation of the use of these applications 
that are successful in vitro have major challenges to overcome in vivo.63 To date, the 
exogenously applied electromagnetic probe stimulations in patients have generated 
highly variable current density and voltage distributions that have led to high 
discrepancies in the reported clinical trials. Currently, electromagnetic stimulation is 
being utilized in some non-healing chronic wounds but there are no FDA-approved 
devices for the indication of chronic skin wounds due to the lack of significant well-
controlled randomized clinical trials and standardization of the devices used for electrical 
stimulation. Currently, scientists remain baffled as to how cells actually sense 
electromagnetic fields.8,9 
 
We will discuss our experiments that have been conducted to show how the 
treatment with a device called the Cellular Energy Transfer Science (CETS) system that 
uses an electromagnetic field could open the door for future wound care applications. The 
CETS system has been used across the globe for 20 years in holistic markets and 
administered in the form of footbaths and baths with reports of pain relief, increased 
stamina, improvements in renal and hepatic function, support in cancer treatment 
recovery, decreased recovery time from illness and injury and many other health 
applications.15 Users of this device have also reported faster or improved wound healing 
after immersing part or all of their body in the water for 20–35 minutes every other day. 
In chapter 2 I showed that the noncancerous cell lines did not exhibit a growth inhibition 
when exposed to the CETS treated growth media and this along with the anecdotal 
testimonials from across the globe led us to conduct cell migration experiments. We will 
discuss the scratch assay, membrane potential assay and microarray analyses that when 
coupled with anecdotal reports from across the globe, offer a strong argument for future 
translation to chronic wound clinical trials. We hypothesized that there would be a 
differential effect on cell migration between treated and control groups of murine 
fibroblasts (L929 cells). 
 
 
METHODS 
 
Murine Fibroblasts (L929 cells), treated (5 x 105) (n = 18) and control (5 x 105) 
L929 (n = 18) were cultured in 60 mm petri dishes in standard Dulbecco’s Modified 
Eagles Medium (DMEM) with 10% fetal bovine serum (FBS) and allowed to grow to 
90% confluence; then, a 3mM hypotonic saline solution that had been treated with the 
CETS system was used to prepare treated media. DMEM 10X from Sigma Aldrich 
Laboratories was diluted 9:1 with CETS treated water and glucose, sodium bicarbonate, 
folic acid, glutamine and fetal bovine serum (10%) were added to achieve a high glucose 
DMEM- 10 high glucose concentration (See Chapter 2). DMEM 10x was also diluted 9:1 
with 9 parts of a 3mM hypotonic saline solution that had not been treated with the CETS 
unit to 1 part DMEM 10X to achieve a DMEM-10 with high glucose concentration. The 
standard DMEM–10 that the cells were initially cultured in was aspirated and replaced 
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with control and treated media in the respective plates. Then, a “scratch” in the cell 
monolayer was made with a p200 pipet tip that was attached to low suction. It is 
important to create scratches of approximately similar size in the cells to minimize 
possible variation by the difference in the width of the scratches. Three scratches in 
parallel were made on each 60mm dish along with 2 reference points that consisted of 
two perpendicular lines to the scratch lines made with a permanent marker on the bottom 
of the dishes. These reference points are critical to ensure consistent orientation to the 
same microscopic field when taking pictures and to insure accuracy of these 
measurements. We made sure we kept the reference lines in the picture for a reference 
point in each scratch to insure we were photographing the same cell growth point of each 
photograph at each time interval. 
 
Pictures were taken along each scratch/wound at the time of scratch and then at 3 
hour intervals until confluence in the treated group was reached at12 hours with a 10x 
eye piece and 40x objective utilizing AxioVision Imaging System. This time interval was 
based on known doubling times of this cell line. The cells were placed in a 37o C/CO2 
incubator between picture time points. 
 
Quantification of cell migration rate can be reported by the percentage change in 
area over time (Equation 1): 
 
M (t) = A (t) – A (0) x 100 
A (0)  Eq. 1 
 
Where A (0) is the initial area enclosed by the population of cells, A (t) is the area 
enclosed by the population of cells at time t, and M (t) is the percentage change in area at 
time t. Estimates of cell migration rates using this equation are often obtained by hand 
tracing that area enclosed by the leading edge of a spreading cell population and this can 
be subjective. To overcome this limitation, we used an automated image analysis 
software, ImageJ to outline the leading edge of the cell migration. ImageJ is a public 
domain, Java-based image processing program developed at the National Institutes of 
Health. It performs standard image processing functions such as logical and arithmetical 
operations between images outlined by sharpening, smoothing, edge detection and 
median filtering in order to develop geometric transformations and accurate measurement 
of the area of the wound. This accurate measurement of the wound area can then be used 
to calculate percent change in area of wound over time. 
 
 
RESULTS 
 
After analysis with ImageJ software to obtain the percent area of wound healed 
over time, we conducted Student’s t-test between the percent change in area at the time 
points of 3 and 9 hours. There was a significant difference in percent area of wound 
healed over time in the treated versus the control groups (Figure 23). On observation of 
the wound picture that was taken at the 9-hour time point in the treated wound (Figure 
24), healing appears to be in an upward fashion from the bottom or an upward directional  
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Figure 23. L292 Cells Scratch Assay- Percent Area Healed/Time. 
L929 cells Scratch Assay; mean (C)-152057; mean (T)-78198.22; df = 16; ts = 5.577858; 
 p = 0.0000416. 
 
 
 
 
 
 
Figure 24. L292 Treated Cells Scratch Assay. 
Baseline (left) and 9 hours (right). 
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migration.  The control wound (Figure 25) appears to lack directional migration (9-hour 
time point) and has few cells that have migrated into the wound as compared to the 
treated wound at the same time point of 9 hours. 
 
 
DISCUSSION 
 
The CETS treated media appears to hyperpolarize the membrane of the murine 
fibroblast when compared to the control group as discussed in Chapter 2 in our 
membrane potential analyses. The treated media also shows increased wound healing 
similar to what is described with the voltage pulsed currents of AC and DC that are 
applied with the probes in vitro.64 The pulsed probed applications have not been effective 
to date in clinical trials.64 The treated wound in Figure 24 shows the treated murine 
fibroblast migrating more quickly, while Figure 25 shows the murine fibroblasts 
migrating sparsely and randomly. We know that injured and proliferating cells have a 
depolarized membrane when compared to non-proliferating cells.19 The CETS treated 
L929 cells show a hyperpolarization or an increase in membrane potential in our assays 
from baseline to 72 hours post treatment. 
 
An Affymetrix microarray was conducted on human breast carcinoma (MDA-
MB231) and human breast epithelial cell (MCF-10A) that had also been grown in the 
CETS treated media and a significant upregulation of genes related to wound healing and 
cancer were found. Two major genes that are associated with multiple pathways are 
vascular endothelial growth factor (VEGF) and Amphiregulin (AREG). VEGFA is a 
member of the PDGF/VEGF growth factor family and encodes a protein that is a 
glycosylated mitogen that acts on endothelial cells and affects angiogenesis, 
vasculogenesis, as well as endothelial cell growth, through the promotion of cell 
migration, cell growth and inhibition of apoptosis. It is associated with 9 different 
significant pathways.63 AREG encodes a member of the epidermal growth factor family, 
which is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells 
and fibroblasts. AREG is related to epidermal growth factor EGF and transforming 
growth factor (TGF-alpha).69 This protein associates with the EGF/TGF-alpha receptor to 
promote the growth of normal epithelial cells while inhibiting the growth of certain 
aggressive carcinoma cell lines.70 Since these genes are strongly implicated in the 
literature as significant targets for wound care treatment and they have been found to be 
significantly upregulated in our microarray analysis of treated versus control human 
breast carcinoma cells and treated human epithelial cells, future plans include QRT-PCR 
validation of these genes in these cell lines is warranted. If validations of the same genes 
are found in these cell lines, hyperpolarization with the CETS system may offer an 
electromagnetic application that could unlock the mystery of electromagnetic signaling of 
cells in vivo that could offer a new wound care treatment. 
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Figure 25. L292 Control Cells Scratch Assay. 
Baseline (left) and 9 Hours (right). 
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CONCLUSION 
 
Wound care presents significant challenges to our health care system. Some 
success has been found in vitro with voltage pulsed currents of AC or DC as well as with 
electrical stimulation of acute wounds in vivo. The CETS system has been shown to 
hyperpolarize the cell membrane and data suggest improved wound healing through 
faster cell migration. The microarray data in our MDA-MB231 and MCF-10A cells 
suggest mechanisms occurring with CETS use may be similar to what has been observed 
in vitro with previous wound care research.63,64 Anecdotal reports of improvements in 
patients with chronic and acute wounds following the use of the CETS are also consistent 
with these in vitro studies.15 Because muscle is also built by the breakdown and 
rebuilding/repair of the muscle cells and fibers as is done by athletes in weight training 
etc., it could be inferred that applications of the CETS might extend beyond acute/chronic 
would care. For example, when a cell membrane can be safely hyperpolarized, the 
damage/breakdown of the muscle fibers that occurs from an athlete with training and 
performance in athletic events could be restored to health more quickly just as the 
acute/chronic wounds appear to respond. This could lead to decreased recovery time as 
well as enhanced performance of athletes as well as expand the application from repair of 
wounds of chronicity to repair of high performance wounds. AREG has been shown to 
participate in certain EGFR and STAT3 signaling, cell cycle progression and in 
tumorigenicity in certain cancers.69,70 AREG has also been shown to be overexpressed in 
wounds that are healing.69,70 Hyperpolarization could be differentially affecting the same 
pathways that are used by both cancerous cells for invasion and proliferation and 
noncancerous cells for migration and healing. Hyperpolarization of the cell membrane 
could be affecting the poorly understood endogenous electrical cues of the cell that 
ultimately lead to the guiding of the cell in ways that are most beneficial to the organism. 
Further bench work and clinical trials are needed to verify the potential beneficial effects 
of the CETS system on cell migration, wound healing and tissue repair. 
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CHAPTER 4.    CELLULAR ENERGY TRANSFER SCIENCE SYSTEM 
MODULATES MAGNETIC IONS IN WATER 
 
 
INTRODUCTION 
 
The Cellular Energy Transfer Science (CETS) system is a device that generates an 
electromagnetic field in water. This device was developed in Australia in 1996 by Terry 
Skrinjar as a water apparatus that was originally designed to affect plants, animals and 
humans by increasing conductivity and water tension is such a way that it positively 
affects ion exchange at the cellular level. This device was one of two devices that 
conformed to the original device and this one which was tested was brought to the United 
States for manufacturing and marketing in Robertsdale, Alabama in 2001. It has been 
marketed in alternative health markets as the Aqua Chi and the Total Charge. This device 
consists of a power pack and a module. The power pack converts alternating current (AC) 
to direct current (DC) and delivers 2.5 amperes of DC to the module that is submerged in 
water. The module is comprised of a set of spaced, electrically conductive stainless steel 
rings that are arranged in parallel on a common axis and with two plates being charged, 
one positively and one negatively and 4 opposing electrically conductive plates (Figure 
26). The center ring/plate is composed of copper and is not part of the circuit since it does 
not have current flowing through it due to the fact it is a non-magnetic metal. The module 
is designed to affect any living organism that comes in contact with the water that has 
been treated with the CETS system. This living organism can be in contact with the water 
in a footbath/bath while the DC is actively running to the module to achieve a direct 
“effect,” or can be placed in the water after the DC has run through the module in the 
water for 30 minutes to achieve an indirect “effect.” People and animals have been taking 
footbaths across the globe with this original design for 20 years to achieve a direct effect 
and we have conducted in vitro experiments where an indirect effect has been 
scientifically tested. 
 
 
BACKGROUND 
 
 
Magnetic Properties of Metal Ions 
 
Every material is known to be influenced in some way by magnetic fields.74 The 
water that was used in these laboratory experiments is de-ionized water that has been 
made to a 3mM NaCl by the addition molecular grade 5M NaCl to supply ions in the 
water so it can carry a measurable current. The rings in the CETS system consist of 
stainless steel and a copper ring. The stainless steel rings contain chromium, nickel and 
molybdenum. Materials can be classified by their response to externally applied magnetic 
fields as diamagnetic, paramagnetic, ferromagnetic and/or anti-ferromagnetic and their 
magnetic responses differ vastly in strength.75 The actual classification of a material’s 
magnetic properties is based on its magnetic susceptibility (X) which is the ratio of the 
induced magnetization (M) to the applied field (H).74 The magnetic moments of  
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Figure 26. CETS Module. 
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ferromagnetic materials align parallel to H and this allows for the coupling interactions 
between electrons of the material leading to very ordered magnetic states.74 The factors 
involved in this process depend on temperature, external field (H) and the atomic 
structures.74 Chloride and copper’s atomic structures lend them to the classification of 
diamagnetic metals.71 Diamagnetism is a very weak magnetism that is nonpermanent and 
persists only when an external magnetic field is being produced. These metals create an 
induced magnetic field in a direction opposite to an externally applied magnetic field and 
are actually repelled by the magnetic field.71 Molybdenum and sodium are paramagnetic 
metals, which are attracted by an externally applied magnetic field and form a magnetic 
field in the same direction of the magnetic field and the strength of this magnetism is in 
proportion to the applied field. Both diamagnetic and paramagnetic metals are considered 
to be nonmagnetic, because they only display magnetism when in the presence of an 
external field.71,76 Nickel is a ferromagnetic metal, which continues to display a 
permanent magnetism with or without a presence of a magnetic field. Magnets are an 
example of ferromagnetism because they retain their magnetic properties. Ferromagnetic 
effects are very large and are considered the strongest form of magnetism and often 
produce magnetism of greater magnitude than an applied field.71,76 Chromium is one of 
the few (2) known anti-ferromagnetic metals in our periodic table. In antiferromagnetic 
materials, the magnetic dipole moments (behaves like tiny magnets) of atoms align in 
opposing directions of the ordered magnetism of ferromagnetic atoms.76 This leads to 
parallel spin of electrons (ferromagnetism), which creates a magnetic moment (polarity), 
and antiparallel spin of electrons (anti-ferromagnetism) which creates an opposing 
magnetic moment (opposing polarity).82,83 The combination of the ferromagnetism and 
the anti-ferromagnetism greatly strengthens the magnetic field produced by the 
spin/current of the electrons in the water.76 
 
 
Magnetic Spin, Magnetoresistance and Lorenz Force 
 
All atoms have inherent sources of varying strengths of magnetism because 
electron spin produces a magnetic moment and the electron orbits act as current loops, 
which produce a magnetic field.81 As stated above, the strength of a field is enhanced, 
when there are both parallel and anti-parallel spinning in electrons from the combination 
of ferromagnetic and anti-ferromagnetic metals that are exposed to that field.82 Giant 
Magnetoresistance (GMR) is a quantum mechanical magnetoresistance effect observed in 
thin-film objects that are composed of alternating ferromagnetic, anti-ferromagnetic and 
non-magnetic conductive layers.83 The 2007 Nobel Prize was awarded to Albert Fert and 
Peter Grunberg for the discovery of GMR where the main application of GMR is a 
magnetic field sensor that is used to read data in hard disk drives, biosensors, 
microelectromechanical systems and other types of devices.72 
 
Magnetoresistance (MR) occurs when the electrical resistance of a material 
changes when a magnetic field is applied to this material.73When an electromagnetic field 
is applied, the magnetic moments of the different magnetic compounds align with respect 
to each other and their magnetizations are parallel. This increased alignment/polarity 
leads to an actual decrease or drop in electrical resistance of the material due to the 
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organizational or uniform spin of the molecules.73 The MR and/or GMR are initiated 
from the interaction of the current carrying the electrons and the magnetization of the 
host magnetic material.73 When electrons have not been exposed to a strong magnetic 
field, the spin-dependent electrons are often scattered and spinning with no organization 
or without the unity of direction that is derived from polarity. In the presence of a 
magnetic field, the spin-dependent electron scattering within the substance will be 
reduced and the electrical resistance will decrease once order is established in the 
organized and unified directional spin of the electrons.73 The parallel (ferromagnetism) 
and the anti-parallel (anti-ferromagnetism) spin induced by the nickel and chromium in 
solution will ultimately order the electrons to spin in a bi-directional fashion. This 
parallel/anti-parallel spin greatly increases the effectiveness and the strength of the 
magnetic field.82 While GMR has been historically applied to solid state materials, many 
chemical, biological, and biophysical reactions occur in liquid environments.73 The chips 
or biosensors that are often used in these processes are microfluidic devices. These 
biosensors are used to detect a bioanalyte’s ability to possess biological recognition of a 
component that acts as a transducer that can measure an electrical output signal.73 Bruce 
Lipton has referred to the cell membrane as an actual microchip that can be considered to 
have the properties of a liquid crystal semiconductor with gates.6 The DNA can be 
considered to be an electromagnetic antennae which is a powerful receiver, transmitter 
and amplifier of frequencies.6 All of these concepts combined with water being the major 
component of life leads to a possible application of magnetism and water as being a 
powerful driver of many chemical and electrical mechanisms in living organisms. 
 
Our in vitro experiments have been conducted with a hypotonic saline solution 
that is exposed to diamagnetic (copper), ferromagnetic (nickel), anti-ferromagnetic 
(chromium) and paramagnetic (sodium and molybdenum) metals that are known 
components of the stainless steel and copper rings in the CETS module, in the presence 
of a magnetic field. A possible hypothesis is that the theoretical parallel and anti-parallel 
spins of the ferromagnetic and anti-ferromagnetic metals could offer a decreased bi-
directional resistance and increased efficiency in the membrane allowing the membrane 
to be more easily gated in order to conduct more work of the cell.  In other words, 
ferromagnetic materials retain highly ordered magnetic states when magnetic moments 
are aligned in the presence of a field.4 The Lorenz force and the right hand rule can be 
used to explain how the electrons will react and the directional movement or the spin they 
will exhibit in relation to the magnetic field and the applied charge.80 The Lorenz force is 
a force that is exerted by a moving external electric field (E).80 The force (F) or direction 
of the spin will always occur perpendicular (either up or down) to both the velocity (v) of 
the charge (q) and the magnetic field (B) (Equation 2). 
 
F = q (E + v x B)        Eq. 2 
 
To further explain the ferromagnetism and anti-ferromagnetic spins of the nickel 
and chromium in the presence of a magnetic field, the ferromagnetic metals spin would 
travel upwards and the anti-ferromagnetic spin would travel downward. If the charge is 
applied in the same direction as the magnetic field, then the magnetic field will be zero 
and non-existent.85 Magnetic fields are very different from electric fields in that they exist 
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only in a three-dimensional fashion. The units of a magnetic field are Newton seconds 
(Coulomb meter) or Newtons per Ampere meter. This unit is named the Tesla.84 
 
 
Metal Ions in Aqueous Solution and Proteins 
 
In aqueous solutions, the water molecules that are attached to the metal ions are 
classified as belonging to the first coordination sphere or the first shell.86, 87 The first 
sphere refers to the central atom or ion and the array of molecules or anions that are 
attached around with a dative covalent bond.86,87 The second coordination sphere includes 
molecules that are attached non-covalently to the ligands by hydrogen bonding.86,87 When 
metal ions are in aqueous solution they are called aqua ions. Aqua ions are in most 
natural waters and are major constituents of seawater. Interestingly, blood also has 
concentrations of aqua ions similar to seawater.87,88,89 When one examines the two 
coordination spheres of the aqua ion, it is known that the second coordination sphere is 
essential in understanding the reactions of this metal complex (metal ion and water) 
because this second complex consists of hydrogen bonding and is involved in 
mechanisms of ligand exchange and catalysis.87,89 These aqua ions play a role in the 
building of many intracellular proteins by serving as a coenzyme or cofactor. 
Metalloproteins are proteins that contain a metal ion cofactor or coenzyme.90,91 A large 
number of proteins fall into this category. It has been estimated that half of all proteins 
contain a metal, while one third of all proteins may also require metals to carry out their 
functions.90 Metalloproteins have been associated with storage and transport of proteins, 
enzymes and signal transduction proteins.90 
 
Due to the relatively unknown and poorly understood mechanisms that could be 
occurring in the water to lead to these interesting experimental effects, we will discuss 
the different water analyses we conducted and the metal ion changes we found between 
the 3mM hypotonic saline solution that had been treated with the CETS unit as compared 
to the control. The various aqueous metal ions that were found are known to have 
differing magnetic properties. These aqueous metal ions and their known magnetic 
differences became the basis for our experiments in this chapter. 
 
 
METHODS 
 
 
Water Analysis of Metal Ions 
 
In order to determine the basis for the biological effects induced by the CETS 
system, we examined the ionic composition of the water before and after treatments and 
after filtering of the treated water by performing a water analysis (Table 5). Eight liters 
of de-ionized water were placed in a 12 liter foot tub plastic wash basin and 5.5 ml of 5M 
NaCl were added from which 500 ml were removed and placed in a clean plastic 
container to serve as the ‘control’ saline solution (per request of A & L). The CETS 
module was then placed in the plastic wash basin and 2.0 amps of current applied for 30  
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Table 5. Analysis of CETS-Treated and Untreated Dilute Saline. 
 
Ion/Element 
  
Control 
(Unfiltered)  
Treated 
(Unfiltered)  
Treated 
(Filtered) 
  Concentration  Concentration  Concentration 
Chloride   205 mg/L  128 mg/L  *NR 
Chromium   1.13 μg/L  22.7 μg/L  18.8 μg/L 
Copper   4.89 μg/L  1600 μg/L  2.69 μg/L 
Iron   <100 μg/L  <100 μg/L  <100 μg/L 
Lead   <0.5 μg/L  <0.5 μg/L  <0.5 μg/L 
Molybdenum   <1 μg/L  2.58 μg/L  2.4 μg/L 
Nickel   <0.5 μg/L  12.1 μg/L  7.49 μg/L 
Sodium   128 mg/L  82.8 mg/L  83.3 mg/L 
Titanium   <1 μg/L  <1 μg/L  <1 μg/L 
*NR-none registered/measured. 
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minutes. Next, 500 ml of the ‘treated’ saline solution was removed and placed in a clean 
plastic container. A separate 500 ml of the ‘treated’ saline solution was run through a 
0.45 micron filter and placed in a clean plastic container. The three containers of the 
control, treated and treated-filtered saline solution were immediately transported for the 
water ion analysis to A & L Analytical Laboratories in Memphis, TN. 
 
 
Comparison Water Analysis with Metal Ions 
 
In order to determine if the biological effects induced by the CETS system could 
be replicated without running DC through the CETS system and by simply adding the 
metal salts noted in the first water analysis in Table 5, we examined the ionic 
composition of the water before and after adding the metal salts to the same 
concentrations (treated) and after filtering of the metal salt water (treated filtered) (Table 
6). Eight liters of de-ionized water were placed in a 12.6 liter foot tub plastic wash basin 
and 5.5 ml of 5M NaCl were added. Then the microgram/liter concentrations of 
molybdenum, chromium and nickel were added to the 3mM hypotonic saline solution. 
Then 500 ml were removed and placed in a clean plastic container and 500 ml were 
removed and run through a 0.45 micron filter (Corning) and placed in a clean plastic 
container. The filtered and unfiltered saline/metal salt solution were immediately 
transported for the water ion analysis to A & L Analytical Laboratories in Memphis, TN. 
  
 
Cell Growth with Metal Salts 
 
We cultured B16, L929 and MDA-MB231 cells in the DMEM-10 with media that 
was reconstituted with a hypotonic saline solution that had chromium, nickel and 
molybdenum salts added to the same concentrations as found in the water analysis (Table 
6) and the control groups of each of the three cell lines were cultured in media that was 
reconstituted with the same hypotonic saline solution that had not been treated with the 
CETS system (See Chapter 2). The treated group of MCF-10A cells was cultured in the 
DMEM/F12-5 media that had been reconstituted with a hypotonic saline solution that had 
chromium (Aldrich Chromium (111) chloride hexa-hydrate, lot # BCBM86667V), nickel 
(Sigma Nickel (11) chloride hexa-hydrate, lot # 054M0001V) and molybdenum (Aldrich 
Molybdenum powder, lot # MKBT3128V) salts added to the same concentrations as 
found in the water analysis (Table 5) and the control group was cultured in media that 
was reconstituted with a hypotonic saline solution that had not been treated with the 
CETS system. On day one, aliquots of 10,000 cells were plated in three 6-well plates for 
each of the two groups in each of the four cell lines. They were plated in their standard 
DMEM-10 or DMEM/F12-5 media on day 1. On day 2, the treated (n=18) and control 
(n=18) media for each of the four cell lines were made and the original standard media 
was replaced in each of the wells with the newly prepared treated and control media. On 
days 3 through 7, wells from the control group and treated group of each cell lines were 
trypsinized, removed from 3 wells of each group and counted using a Scepter Automated  
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Table 6. Comparison of Metal Ions in CETS Treated Filtered and Metal Salt 
Filtered Water. 
 
Ion/Element Magnetism CETS Treated Metal Salts 
Chloride Diamagnetic ↓ 100%   ↑33% 
Copper Diamagnetic ↓99% Not added 
Chromium Anti-ferromagnetic ↓17% ↓32% 
Nickel Ferromagnetic ↓38% ↓02% 
Sodium Paramagnetic ↓00% ↑21% 
Molybdenum Paramagnetic ↓06% ↓58% 
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Cell Counter (Millipore). Remaining wells had the control and treated media replaced 
daily. 
 
 
Cell Growth with Autoclaved CETS Treated Water 
 
We cultured the treated MDA-MB231 cells in the DMEM-10 with media that was 
reconstituted with a hypotonic saline solution that had been treated with the CETS system 
for 30 minutes and was then placed in the autoclave at 120o C for 40 minutes prior to 
making the growth media and the control group was cultured in media that was 
reconstituted with the same hypotonic saline solution that had not been treated with the 
CETS system and autoclaved. On day one, aliquots of 10,000 cells were plated in three 6-
well plates for each of the two groups. They were plated in their standard DMEM-10 
media on day 1. On day 2, the treated (n=18) and control (n=18) media for each of the 
four cell lines were made and the original standard media was replaced in each of the 
wells with the newly prepared treated/autoclaved and control media. On days 3 through 
7, wells from the control group and treated group were trypsinized, removed from 3 wells 
of each group and counted using a Scepter Automated Cell Counter (Millipore). 
Remaining wells had the control and treated media replaced daily. 
 
 
Cell Growth with CETS Treated Water and Magnet 
 
We cultured the MDA-MB231 cells in the DMEM-10 with media that was 
reconstituted with a hypotonic saline solution that had been treated with the CETS system 
for 30 minutes and was then placed in test tubes that were placed next to a magnet for 24 
hours prior to making the growth media and the control groups were cultured in media 
that was reconstituted with the same hypotonic saline solution that had not been treated 
with the CETS system and had been both exposed to magnet and not exposed to magnet. 
On day one, aliquots of 10,000 cells were plated in three 6-well plates for each of the two 
groups. They were plated in their standard DMEM-10 media on day 1. On day 2, the 
treated (n=18) and control (n=18) media for each of the four groups were made and the 
original standard media was replaced in each of the wells with the newly prepared 
treated/magnet and control/magnet media. On days 3 through 7, wells from the control 
group and treated group were trypsinized, removed from 3 wells of each group and 
counted using a Scepter Automated Cell Counter (Millipore). Remaining wells had the 
control and treated media replaced daily. 
 
 
RESULTS 
 
 
Metal Ions in the CETS treated Water Analysis 
 
Analysis of water samples found differences in chromium, copper, molybdenum, 
nickel and sodium between treated samples and control (Table 6). In the control water, 
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there is a measurable concentration of chloride, chromium, copper and sodium. The 
chloride and sodium can be attributed to the addition of the molecular grade NaCl to the 
de-ionized water. The chromium and copper are either naturally in the water or are 
deposited from the water pipes etc. The treated water prior to filtering through a 0.45 
micron filter for sterilization with the in vitro experiments, contains more chromium, 
copper, molybdenum and nickel and less sodium and chloride than the control. After 
filtering the treated water, the majority of the chromium, molybdenum, nickel and 
sodium remains, while the copper and chloride appear to be retained by the filter. 
 
 
Metal Ions in Metal Salt Water Analysis 
 
When examining the results of the metal salt water analysis, chloride does not 
remain in solution with filtering after exposure to the magnetic field from the CETS 
system. Chloride does remain in solution after the water is reconstituted with the metal 
salts. Copper also does not remain in solution after filtering once exposed to the magnetic 
field of the CETS system. These are both diamagnetic metals. Chromium is an anti-
ferromagnetic metal and the data suggest it remains in solution at a higher concentration 
after exposure to a field than when added as a metal salt. Nickel is a ferromagnetic metal 
and appears to remain in solution in higher levels when added as a metal salt as opposed 
to when exposed to the magnetic field of the CETS. Sodium and molybdenum are 
paramagnetic metals and appear to remain in solution in higher concentrations once 
exposed to the magnetic field of the CETS system. 
 
 
Cell Growth with Metal Salts 
 
To determine if the growth inhibition was due to the metals that are found in the 
treated filtered water, growth media was made with control water with the same 
concentrations of chromium, molybdenum and nickel salt that was made to correspond to 
the same concentrations as noted in the water analysis of the treated filtered water. We 
found that the doubling time in the metal salt supplemented media has the opposite effect 
seen with the CETS treated water (Figure 27) e.g. the cells grew at the same rate equal to 
that of the non-treated control media. 
 
 
Cell Growth with Autoclaved CETS Treated Water 
 
To determine if heating the water would change the effects of the treated 
water/media on the growth inhibition, we autoclaved treated water autoclaved at 120o C 
and 1.1 bars for 40 minutes prior to making the media to see if it would have a 
differential effect on the growth of cancerous cells compared to non-autoclaved water. 
We did not observe a change in the appearance (e.g. color, precipitate etc.) in the 
autoclaved treated water. We then plated the human breast carcinoma and prepared and 
changed the media daily over 6 days. The doubling times suggests the effects are negated 
with heating the treated water (Figure 28). The heating of metal aqueous ions affects the 
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Figure 27. Metal Salt Experiments. 
A 3mM saline solution that was identical to the solution used in all the previous 
experiments was made. Instead of treating with the CETS system, nickel, chromium and 
molybdenum salts were added to the hypotonic saline solution in order to achieve their 
same concentrations as found in the CETS treated-filtered water by the analysis of an 
independent laboratory. All four cell lines were cultured in standard media and the 
control and metal salts media were added to the wells on Day 2 and the media was made 
and replaced daily. Wells were also counted in triplicate daily. Data were analyzed with 
unpaired two-tailed t-tests. 
(A) Murine melanoma; mean control 385536.2; mean treated 973811.4; df = 40; 
ts =-2.21586; p = 0.032455. (B) Murine fibroblasts; mean control 295167.1; mean treated 
583794.8; df = 40; ts = -2.13383; p = 0.03904. (C) Human breast carcinoma; mean 
control 319071.4; mean treated 446895.2; df = 40; ts = -0.98762; p = 0.329275. (D) 
Human epithelial cells; mean control 65259.52; mean treated 78675.19; df = 40; 
ts =-0.54548; p = 0.588451. 
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Figure 28. MDA-MB231 Cell Autoclave Experiment. 
MDA-MB231 cells plated in media made with treated CETS saline after autoclaving. 
Data were analyzed with unpaired t-tests; mean control 659690.5; mean treated 
571904.8; df = 40; ts = 0.433124; p = 0.667251. 
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magnetic behavior of these metal ion complexes and is known to exhibit this phenomena 
from 25o C and 1 Bar to 5000oC.28 The data suggests that heating in the autoclave to 
120oC and 1.1 bar could be leading to a change in the magnetic behavior of the metal 
aqueous ions thereby negating their effects. 
 
 
Cell Growth with CETS Treated Water and Magnet 
 
To determine if the effect is due to magnetism, we hypothesized that treated water 
exposed to the magnet for 24 hours prior to making the media would have a differential 
effect on the growth of cancerous cells compared to the control water exposed to the 
magnet for 24 hours. We exposed both control and treated media placed in a test tube to a 
magnet. We found that there was a significant difference between the treated group 
exposed to the magnet and the treated group that was not exposed to the magnet, while no 
difference in the growth was noted between the control groups when the control water 
was exposed or not exposed to the magnet (Figure 29). This suggests the CETS induced 
effect in the water that has contributed to growth inhibition, cell cycle arrest, membrane 
potential change and genomic effects noted in our experiments is affected by exposure to 
another magnetic field and this field was generated by the magnet. 
 
 
DISCUSSION 
 
The CETS system uses a Lorenz force with DC that is applied through a cathode 
and an anode in a perpendicular fashion to a set of metal rings that consists of 
diamagnetic, paramagnetic, ferromagnetic and antiferromagnetic metals. These rings are 
placed in water where they create an electromagnetic field in the presence of this current.  
The copper or diamagnetic ring sits in the center of the stainless steel rings which 
separates the field traveling through the anode and cathode pathways and helps to create 
the perpendicular field to the current. Lorenz force is being produced by current being 
applied in perpendicular fashion to the magnetic field. The persisting and possible 
permanent change in the ferromagnetism and its associated parallel spin that is displayed 
by the nickel, and the change in the anti-ferromagnetism and its associated anti-parallel 
spin that is displayed by the chromium, leads to the increased strength of the magnetic 
field (GMR) and organizational polarity. These concepts suggest that it is possible that a 
magnetic change in the saline/metal ion solution is being induced by applying an 
electromagnetic field to these metals in the presence of this water. Since ferromagnetism 
persists in the absence of a field, this would suggest that the parallel spin (nickel) and 
anti-parallel spin (chromium) of electrons would persist in the growth media (that was 
made with the treated hypotonic saline solution) when it is used to grow the cancerous 
and noncancerous cells in vitro in our experiments. The bi-directional spin of metal ions, 
induced by a strong parallel, anti-parallel spin of the magnetic metals, could decrease the 
electrical resistance in the cell membranes that is exhibiting increased electrical 
resistance due to the lack of ordered spin that could be occurring in the depolarized 
cancerous and/or proliferating cells. This cell membrane or microchip is known to be 
gated with cell signaling mechanisms and it is known to carry a charge.8 The organized  
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Figure 29. MDA-MB231 Magnet Experiment. 
Control magnet exposed and non-magnetic exposed water was used to make the growth 
media. This suggests the CETS induced effect in the water that has contributed to growth 
inhibition, cell cycle arrest, membrane potential change and genomic effects noted in our 
experiments is affected by exposure to another magnetic field and this field was 
generated by the magnet. Data analyzed with unpaired t-tests and showed no significant 
difference in growth; control magnetic exposed mean 659690; control non-magnetic 
exposed mean 571904.8; ts = 0.781225; df = 40; p = 0.43927. Treated magnet-exposed 
and treated non-exposed showed a significant difference in growth; treated magnetic 
exposed mean 145748.6; treated non-magnetic exposed mean 41152.38; ts = 2.61961;  
df = 40; p = 0.012379. 
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nature of the magnetic resistance could in fact be decreasing the electrical resistance and 
allowing a more organized flow of ions through the liquid crystal semiconductor 
membrane. Movement of charges due to lateral diffusion within a plasma membrane is 
essentially a rotating magnetic field.97 The parallel and anti-parallel spins, as well as the 
accompanying paramagnetic changes in organizational spin, could offer a decreased bi-
directional resistance in the membrane, allowing the membrane to be more easily gated in 
order to conduct more work of the cell. These metal ions that are formed after exposure 
to the electromagnetic field that is applied to the hypotonic saline solution by the CETS 
system may also be a factor in protein synthesis in the intracellular matrix due to the 
interaction with the cell membrane. The charged ions could possibly be developing dative 
covalent bonds with the water molecule in the presence of the electromagnetic field in the 
first coordination sphere.92,93,94 These bonds create the spins that are known to occur with 
the magnetism of the specific metals. This will then offer an opening for second 
coordination sphere non-covalent hydrogen bonding that can lead to the development of 
metal ion cofactors that can be used for the initiation of protein synthesis.92,93 A major 
site of the interaction of a divalent metal ion and a nucleotide has been shown to be 
between the cation and the phosphate chain.77 A major complex of divalent cations and 
nucleotides is known to consist of ATP.77 There is an interaction of divalent ions with the 
ring of nitrogen atoms in nucleotides and this interaction has been studied with the use of 
paramagnetic and ferromagnetic ions showing significant changes in the proton magnetic 
resonance spectra of these nucleotides. 92 It has also been noted that complexes of 
magnesium (paramagnetic) with nitrogenous ligands are considerably weaker than the 
complexes of nickel (ferromagnetic) and this corresponds to the strength of the 
magnetism associated with these metal ions.77, 24  The factors that govern metal binding 
affinity and selectivity in proteins range from: 1) intrinsic properties of the metal, 2) 
primary coordination sphere, 3) secondary coordination sphere, 4) protein matrix, 5) bulk 
solvent, 6) competing non-protein ligands from the surrounding biological environment.95 
Once the field is created and the metal ions begin to attach to the water molecules in the 
first coordination sphere, they can then also begin to interact with the cell membrane and 
become a possible cofactor or catalyst for the initiation of metalloproteins in the 
membrane proteins and intracellular matrix through hydrogen (non-covalent) bonding 
that occurs in the second coordination sphere.89 
 
The differing concentrations of the different metal ions that remain in solution 
after the filtering process once they have been exposed to the magnetic field by the CETS 
system, when compared to the concentration that remain in solution after the addition of 
the metal salts, could be a possible mechanism that may have a magnetic basis. When the 
treated water that contained the metal ions was immediately heated in an autoclave, our 
experiments show this heating decreased the growth inhibitory effect of the treated 
media. The growth inhibitory effect was also decreased after the treated water was 
exposed to a magnet and its magnetic field prior to making the growth media for 
culturing. The growth inhibitory effects was also reduced once the media was made with 
the treated water while the treated water appears to hold the effect when left unexposed to 
high temperatures, other magnetic fields and other metal ions. We know that the 
magnetic properties of metal ions are sensitive to temperature and magnetic fields.96 
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CONCLUSION 
 
The concept of magnetic drug targeting has been around for over 30 years and 
magnetic nanoparticles are a class of engineered particulate materials of <100nm that can 
be influenced or manipulated by an external magnetic field.79 Targeting of drugs by 
nanoparticles is intended to decrease drug waste, frequency of administration, reduce side 
effects, and increase sustained delivery to desired organ target.74 There has been limited 
success due to magnetic forces generally being short ranged and underwhelming to the 
hydrodynamic forces in the body.74,79 Magnetic nanoparticles consist of magnetic 
compounds, such as iron, nickel, cobalt and their oxides. My experimental data suggest 
significant effects on cell growth, cell cycle, membrane potential, cell migration and 
genomic expression with the CETS treated water. Could the electromagnetic field be 
inducing a modulation in the magnetic structure of the water? When one examines these 
metal ions that remain in the treated-filtered water, the concentrations of these metal ions 
(chromium, nickel, sodium and molybdenum) is strikingly similar to their concentrations 
in seawater and blood. These similar concentrations make an interesting correlation to the 
concept of how we are connected to the naturally occurring water that is said to be the 
‘staff of life.’ 
 
The effects in our experiments appear to also be differentially expressed with the 
observations of growth inhibition of cancerous cells and lack of growth inhibition in 
noncancerous cells.  Increased cell migration was also observed in the mouse fibroblasts 
with wound care data which shows an application for wound healing. Quantification of 
the possible magnetic nanoparticle effects, if any, warrant further investigation. The 
CETS system could offer a form of magnetic nanoparticle augmentation that utilizes a 
hypotonic saline solution that is exposed to a carefully designed set of metal rings in the 
presence of an electromagnetic field and that produces metal aqueous ions that interact 
with the cell membrane and significantly affect cell behaviors. Due to the fact that the 
addition of the metal salt/ions to exact molar concentrations found in the treated filtered 
water analysis did not yield the same differential cell growth results in our laboratory 
experiments; the data suggest the metal ions may only form a divalent covalent bond in 
water in the presence of an induced electromagnetic field. Therefore, DC, metal rings, 
water (with ions) and electromagnetic field may be all needed to produce the aqueous 
metal ion solution that is needed to achieve the biological effects noted in these 
experiments and quite possibly in the anecdotal reports that have occurred across the 
globe over the last 20 years with use of the CETS system. When we review the 
susceptibilities or criteria for inducing magnetic moments into materials, they are: 
temperature, external field H and atomic structure. The in vitro experiments were 
conducted with an aqueous solution that had previously been exposed to the external field 
H but was not actively present during the cell culturing and growth phases.  We also 
conducted these experiments after exposing the treated aqueous solution to high 
temperatures of the autoclave. It is known that at sufficiently high temperatures (blocking 
temperature) thermal energy is the catalyst that induces free rotation of the particle 
resulting in a loss of net magnetization in the absence of an external field.78 The data 
suggest that the metal ions are only catalysts or cofactors for metalloproteins, when they 
are formed in the presence of current through a magnetic field in the medium of water. If 
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these metal ions are forming covalent bonds, the dissociation of these bonds explain the 
nullification of the effects seen with heating the treated water in the autoclave due to the 
high temperature negating effects. Lastly, the exposure of the treated water to the 
magnetic field of the magnet also appeared to reduce the effects of the treated water on 
the cell growth. If magnetism was involved in the effects seen in our experiments, then 
the exposure to a field could be a factor in influencing the directional spins induced by 
the CETS system. These results suggest our experiments may be possibly showing effects 
that are known to exist in the magnetic nanoparticle world but have remained elusive in 
their application for health. Due to the fact that the CETS has shown many anecdotal 
health benefits across the globe and that this work is showing significant experimental 
effects that appear to correspond to these phenomena, future research into responsible 
mechanisms are warranted. 
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CHAPTER 5.    DISCUSSION 
 
 
These experiments have been conducted in this dissertation research to test 
whether there are differential growth effects when cancer cells are maintained in media 
reconstituted with the water treated by the CETS system. Experimental data showed 
cancerous cell growth inhibition while not affecting noncancerous cell growth. This 
cancer cell growth inhibition also showed cell cycle arrest, hyperpolarization of plasma 
membranes, annexin staining and genomic upregulation of ER stress/UPR as well as the 
p53 oncogene. This CETS treated water analyses also suggests a possible modulation of 
the magnetic behavior of metal aqueous ions. 
 
Our experiments show a correlation to the Rogerian theoretical framework that 
suggests that bioelectrodynamics can utilize an electrical energy source that affects not 
only the organism but the field immediately surrounding the organism. The tertiary 
interaction of these three components: 1) energy source (DC), 2) environment (water), 
and the 3) organism (cells) are all involved in the process of bioelectrodynamics. This 
data gives quantitative measurements of a previously abstract concept that has often 
failed to obtain data that is readily accepted by the scientific community. The microarray 
and genomic validations revealed some interesting results that while unexpected, show 
some interesting possibilities for future work with many chronic co-morbidities. The 
UPR is linked to many chronic co-morbidities in the literature that include but are not 
limited to: cancer, hyperlipidemia, allergies, asthma, COPD, cystic fibrosis, autism, ALS, 
Parkinson’s disease, Huntington’s disease, organ fibrosis, diabetes and many more.  
Proteins must be folded in appropriate fashion in order to be able to be used by the cell 
and ultimately an organism. It has been estimated that if we took a penny to represent 
every cellular protein, it would fill up the Pacific Ocean with these pennies. The number 
of proteins a cell must properly fold is vast. If the proteins are not properly folded, this 
can lead to toxicity in the cell/organism. Cancer cells hijack the UPR and exploit the 
pathway in order to survive and avoid programmed cell death. Neurons in the brain enter 
into programmed cell death when unfolded proteins begin accumulating in patients 
leading to amyloid fibrils that contribute to the development of the neurodegenerative 
diseases of ALS, Parkinson’s disease and Huntington’s disease. Many allergies are 
caused by an incorrect folding of some proteins leading to a failure of the immune 
system’s production of antibodies for certain protein structures. Misfolding and excessive 
degradation of proteins are linked to cystic fibrosis and lysosomal storage disease. Our 
experiments show that external factors of high temperatures of the autoclave and external 
fields (electric, magnetic), have an effect on protein folding. Folding is a process that can 
require ATP energy for recruitment of chaperones or occur spontaneously with inputs 
from the nucleoside triphosphates. The folding of proteins is believed to be enhanced by 
intramolecular hydrogen bonds and is opposed by an energy deficit. In theory, the 
hyperpolarization of the cell membrane in our experiments could be reducing factors that 
lead to ER stress and problems with protein folding. The genomic analyses with the 
MDA-MB231 and MCF-10A cells suggest that a change in the magnetic behavior of the 
aqueous metal ions may prevent the cancer cell from hijacking the UPR for survival. The 
data from the genomic analyses from the MCF-10A cells also suggests that it may help 
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relieve the ER stress and therefore prevent programmed cell death in noncancerous cells. 
Also, the upregulation of Amphiregulin (AREG) in the MCF-10A cells microarray could 
offer a genomic link to spark wound care clinical trials. The TNFRSF9 gene upregulation 
could help with the internal immune response activation in the fight against the 
cancerous, inflamed and injured cells. 
 
Magnetic nanoparticle therapies have been widely used in drug delivery and 
hyperthermia treatments for cancer. Recent applications of magnetic nanoparticles have 
shown great promise towards decreasing infections and tissue growth. To continue to 
build this science, much future research is warranted in order to translate this application 
more fully to mainstream medicine.98These magnetic nanoparticles have been used to 
augment chemicals that are foreign to the body. When one looks at the building block of 
the body, the cell, it is known that they are composed of water, inorganic ions and 
carbon-containing molecules. Water is the most abundant molecule in cells. Therefore, 
our understanding of water and the other constituents and how they act and interact 
together are paramount in the study of biology. Because of the polar nature of water 
molecules, they can form hydrogen bonds with both other polar molecules and well as 
with positively and negatively charged ions. The study of proteolysis could also provide 
answers to the wide range of conditions under which this protein folding could be 
analyzed. Water may be the essential component to bridge the magnetic nanoparticle 
world to living organisms that warrants further experimental testing. Chapter 4 delves 
into the key components of the water structure that undergo change with the CETS 
treatment. We have much to learn about how these magnetic ions and their solubility and 
other behavioral changes in the CETS treated water are actually driving or changing the 
behavior of the cells with regards to cell growth, cell migration, cell cycle progression, 
cell size, membrane potential, cell death and genomic level changes. The mechanisms 
may be occurring quickly and in multiplicity and will take many experimental studies to 
begin to piece together the puzzle as to how these cellular behaviors become so 
significantly altered. 
 
Cancer will affect one in three individuals over their lifetime. Drugs that treat 
cancer and wounds are so expensive, the costs are affecting the care of patients with these 
chronic co-morbidities and our health care system.99 Mayo Clinic recently introduced 
seven actions that could reduce the cost of cancer drugs and improve the ability for 
patients to receive adequate treatment. One action they considered is allowing the 
Patient-Centered Outcomes Research Institute-which the Affordable Care Act initiatives 
created to evaluate the benefits of new treatments. They recommend similar organizations 
include pricing in their assessment of treatment value. The financial burdens placed on 
the health care system for treatment of cancer and wounds have to be addressed as we 
progress into future options for these patients. The CETS system can offer an adjunct that 
is affordable to our health care system. It appears that CETS system needs to be taken to 
both animal models and to clinical trials to evaluate the effectiveness of this as a future 
adjunct treatment for cancer, wounds and other chronic co-morbidities. We have seen the 
toxicity and failure of many current cancer and wound care treatments for decades. When 
done in combination with chemotherapy and radiation, the upregulation of both UPR and 
the JMY/p53 oncogene by the CETS treated water could help decrease the toxicity of 
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these treatments allowing for the patients to complete the standards of care that are 
currently FDA approved and in oncological practice. Clinical trial testing with the CETS 
system could offer hope and improved outcomes to mankind. 
 
We have a phase 1 safety trial for the CETS system approved by the UTHSC IRB 
and will be conducting the study in early 2016.  This safety trial along with the 
experimental data and case study data we are collecting from anecdotal reports, will 
provide critical and essential data that could allow the CETS system to be used in patients 
in the areas cancer and wound care and lay the foundation for additional studies in other 
chronic co-morbidities that are connected to the UPR. These actions could help lead to a 
future paradigm shift in how we address life, health and wellness. There are many policy 
obstacles to overcome in the future in order to bring this device to market. Due to the 
transition from a Newtonian Physics based application to a quantum physics based 
application of the CETS system, great efforts will be needed to overcome provider bias 
and skepticism. The experimental, animal models and clinical trial data will be critical to 
establish the scientific basis in order to gain scientific credibility and validity. There will 
also be obstacles to overcome that favor medication reimbursement for cancer therapies. 
Ultimately all the stakeholders will need to see the safety, efficacy and profitability with 
use of the CETS for future treatments in order for this to move forward in the 
marketplace and for the benefit of mankind. Research funding is warranted for in order to 
pursue the possibilities from the significant experimental, anecdotal and genomic results 
presented in this work. 
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